Page last updated: 2024-08-16

risperidone and paliperidone palmitate

risperidone has been researched along with paliperidone palmitate in 376 studies

Research

Studies (376)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	19 (5.05)	18.2507
2000's	106 (28.19)	29.6817
2010's	203 (53.99)	24.3611
2020's	48 (12.77)	2.80

Authors

Authors	Studies
Heykants, J; Lorreyne, W; Van Rompaey, F; Woestenborghs, R	1
Heykants, J; Huang, ML; Mannens, G; Meuldermans, W; Snoeck, E; Van Beijsterveldt, L; Van Peer, A; Woestenborghs, R	1
Janssen, PM; Leysen, JE; Megens, AA; Schotte, A	1
Geerts, RJ; Heykants, JJ; Leysen, JE; Megens, AA; Meuldermans, WE; van Beijsterveldt, LE; Van den Eynde, HM	1
Heykants, J; Mannens, G; Meuldermans, W; Snoeck, E	1
Edouard, S; Le Moing, JP; Levron, JC	1
Hoffman, DW; Price, MC	1
Linnet, K; Olesen, OV	1
Aravagiri, M; Marder, SR; Wirshing, D; Wirshing, WC	1
Bruun, T; Licht, RW; Linnet, K; Olesen, OV; Thomsen, E; Viftrup, JE	1
Aravagiri, M; Marder, SR; Yuwiler, A	1
Baker, GB; Bourin, M; Fang, J	1
Albano, D; Amchin, J; Klockowski, PM; Taylor, KP; Zarycranski, W	1
Cho, MJ; Jang, IJ; Kwon, JS; Lee, DY; Lee, KU; Shin, SG; Woo, JI	1
Bork, JA; de Leon, J; Rogers, T; Wedlund, PJ	1
Saria, A; Schatz, DS	1
Avenoso, A; Dahl, ML; Facciolà, G; Johansson, I; Scordo, MG; Spina, E	1
Doorschot, CH; Loonen, AJ; Oostelbos, MC; Sitsen, JM	1
Furukori, H; Kaneko, S; Nagasaki, T; Ohkubo, T; Sugawara, K; Yasui, N	1
Hackett, LP; Hill, RC; Ilett, KF; McIvor, RJ; Wojnar-Horton, RE	1
Cui, D; Kamel, A; Miceli, JJ; Prakash, C; Tweedie, D; Whalen, RD	1
Chang, WH; Chiu, WC; Chou, JC; Lane, HY; Su, MH; Wu, ST	1
Aravagiri, M; Marder, SR	2
Nakamura, J; Terao, T; Ueda, N; Yoshimura, R	1
Avenoso, A; Facciolà, G; Giacobello, T; Madia, AG; Perucca, E; Salemi, M; Scordo, MG; Spina, E	1
Aamo, T; Güzey, C; Spigset, O	1
Avenoso, A; Facciolà, G; Salemi, M; Spina, E	1
Ancione, M; Avenoso, A; Facciolà, G; Madia, AG; Perucca, E; Salemi, M; Scordo, MG; Spina, E	1
Ancione, M; Avenoso, A; Facciolà, G; Madia, A; Scordo, MG; Spina, E	1
Nakamura, J; Ueda, N; Yoshimura, R	1
Déridet, E; Moore, N; Titier, K	1
Abouelfath, A; Cardone, E; Déridet, E; Moore, N; Titier, K	1
Kastango, KB; Kirshner, MA; Maxwell, RA; Mulsant, BH; Pollock, BG; Rosen, J; Sweet, RA	1
Fukuda, M; Iga, T; Nakashima, Y; Ohno, Y; Sato, H; Sawada, Y; Takayanagi, R; Tsuchiya, F; Yamada, Y	1
Thiam, S; Valle, BC; Warner, IM; Zhu, X	1
Berecz, R; Cáceres, M; de la Garza, CS; Dorado, P; Gutiérrez, JR; LLerena, A; Norberto, MJ	1
Huang, F; Janssens, L; Lasseter, KC; Lau, H; Verhaeghe, T; Zhao, Q	1
de Jong, J; de Vries, R; Hooijschuur, EW; Remmerie, BM; Schothuis, AM; Sips, LL; van de Merbel, NC	1
Berecz, R; de la Rubia, A; Degrell, I; Dorado, P; Gómez, J; Kellermann, M; LLerena, A	1
Xiao, H; Yang, J; Zhang, S; Zhang, X	1
De Vries, R; Iga, T; Kaneko, S; Kondo, T; Kubota, T; Mihara, K; Takarada, Y; Tateishi, T; Yasui-Furukori, N	1
de Vries, R; Iga, T; Ishida, M; Kaneko, S; Kondo, T; Kubota, T; Mihara, K; Ono, S; Suzuki, A; Takarada, Y; Yasui-Furukori, N	1
Ko, G; Lasseter, KC; Lechat, P; Mannaert, E; Remmerie, BM; van Schaick, EA	1
Aravagiri, M; Gitlin, MJ; Marder, SR; Nuechterlein, KH	1
Begg, EJ; Gardiner, SJ; Hackett, LP; Ilett, KF; Kristensen, JH; Vaddadi, KS	1
Aman, M; Flarakos, J; Gerber, N; Luo, W; Svinarov, D; Vouros, P	1
Chang, JW; Chen, PS; Liao, YC; Su, SF; Yang, YK; Yeh, TL	1
De Vries, R; Kaneko, S; Kondo, T; Mihara, K; Nakagami, T; Suzuki, A; Takahata, T; Tateishi, T; Yasui-Furukori, N	1
Calamoneri, F; D'Arrigo, C; Gagliano, A; Germanò, E; Impallomeni, C; Pustorino, G; Spina, E	1
Ancione, M; D'Arrigo, C; Madia, A; Migliardi, G; Morgante, L; Spina, E; Zoccali, R	1
Berecz, R; de la Rubia, A; Dorado, P; Llerena, A	1
De Clerck, F; Eerdekens, M; Greenspan, A; Mannaert, E; Somers, Y	1
Foltz, RL; Huang, W; Laycock, JD; Moody, DE	1
Möller, HJ; Müller, N; Müller-Arends, A; Riedel, M; Schwarz, MJ; Spellmann, I; Strassnig, M; Weber, K; Zach, J	1
Castberg, I; Spigset, O	1
DeVane, CL; Donovan, JL; Markowitz, JS; Ruan, Y; Taylor, RM; Wang, JS	1
Björner, A; Eerdekens, M; Eriksson, B; Gefvert, O; Helldin, L; Mannaert, E; Nyberg, S; Persson, P; Remmerie, B	1
Aichhorn, W; Stuppaeck, C; Whitworth, AB	1
Goto, M; Kaji, K; Kakihara, S; Matsumoto, C; Nakamura, J; Ohmori, O; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R	1
Baselmans, P; Bosker, F; Bruggeman, R; Castelein, S; Knegtering, R; van den Bosch, RJ	1
Aichhorn, W; Geretsegger, C; Kemmler, G; Marksteiner, J; Stelzig-Schoeler, R; Stuppaeck, C; Walch, T; Weiss, U; Zernig, G	1
Kaneo, S; Nakagami, T; Saito, M; Tateishi, T; Yasui-Furukori, N	1
Kapur, B; Koren, G; Railton, CJ	1
Furukori, H; Kaneko, S; Nakagami, T; Saito, M; Yasui-Furukori, N	1
Chan, YH; Chong, SA; Tan, CH; Verma, SK	1
Byun, WT; Cho, HK; Jung, IG; Jung, SM; Kim, KA; Park, JY; Park, PW	1
Ariën, A; Brewster, M; Mathot, F; Préat, V; van Beijsterveldt, L	1
Deng, CY; Li, HD; Li, WB; Li, X; Lin, QX; Lin, SG; Peng, HY; Su, FL; Wang, CY; Wang, F; Yang, M; Yu, XY; Zhou, ZL; Zhu, RH	1
Kapur, S; Labelle, A; Mamo, D; Mann, S; Mannaert, E; Reiss, J; Remington, G; Shammi, C	1
Hendset, M; Nesvåg, R; Refsum, H; Tanum, L	1
Bhatt, J; Singh, S; Subbaiah, G	1
Didriksen, M; Kreilgaard, M; Olsen, CK	1
DeVane, CL; Donovan, JL; Markowitz, JS; Wang, JS; Zhu, HJ	1
Cho, HY; Lee, YB	1
DeVane, CL; Donovan, JL; Gibson, BB; Markowitz, JS; Wang, JS; Zhu, HJ	1
Duan, S; Feng, G; Gao, R; He, L; Li, H; Meng, J; Qin, S; Xing, Q; Xu, M; Zhang, A	1
Melkersson, KI	1
Ludwig, EA; Piotrovsky, V; Vermeulen, A	1
Buitelaar, JK; Hermans, MH; Hoekstra, PJ; Lahuis, BE; Minderaa, RB; Scahill, L; Troost, PW; van Engeland, H	1
Nakamura, J; Shinkai, K; Ueda, N; Yoshimura, R	1
Cabovska, B; Cox, SL; Vinks, AA	1
Hori, H; Kakihara, S; Mitoma, M; Nakamura, J; Nakano, Y; Ohta, M; Shinkai, K; Shinkai, T; Sugita, A; Ueda, N; Umene, W; Yoshimura, R	1
D'Hoore, P; Kushner, S; Mannaert, E; Remmerie, B; Thyssen, A	1
Blier, P; Dremencov, E; El Mansari, M	1
Diaz, FJ; Leon, Jd; Orrego, ML; Pan, RM; Susce, MT; Wedlund, PJ	1
Piniella, PM; Relleke, M; van Os, S	1
Canuso, CM; Kujawa, M; Mahmoud, R; Pandina, GJ; Youssef, E	1
Azarzar, D; Bartélémy, C; Bonte, JP; Chaminade, P; Danel, C; Odou, P; Vaccher, C	1
Azarzar, D; Barthélémy, C; Bonte, JP; Danel, C; Odou, P; Robert, H; Vaccher, C	1
Ding, JJ; Jiao, Z; Shi, XJ; Yu, YQ	1
Du, J; Fang, C; Feng, GY; Gu, NF; He, L; Li, XW; Qin, SY; Wang, L; Xing, QH; Yu, L; Zhang, AP	1
Bartlett, MG; Terry, AV; Zhang, G	1
Aman, MG; Lindsay, RL; Malone, K; Mannaert, E; Masty, J; Ramadan, Y; Remmerie, B; Vinks, AA	1
Crocq, MA; Duval, F; Garcia Duarte, F; Guillon, MS; Mokrani, MC	1
Awouters, FH; Lewi, PJ	1
Kim, KA; Kim, KB; Lee, HJ; Liu, KH; Park, JY; Park, PW; Shin, JG	1
Henken, S; Hiemke, C; Kirschbaum, KM; Schmitt, U	1
Dopheide, JA	1
Deyo, Z; Dolder, C; Nelson, M	1
Nussbaum, A; Stroup, TS	1
Bossie, CA; Canuso, CM; Schreiner, A; Simpson, GM; Turkoz, I; Youssef, EA	1
Boom, S; De Meulder, M; de Vries, R; Hooijschuur, EW; Remmerie, BM; Sips, LL; Timmerman, PM; van de Merbel, NC	1
Darby, JK; Herbert, J; Pasta, DJ; Wilson, MG	1
Dahl, ML; Gunes, A; Scordo, MG; Spina, E	1
Eliasson, E; Mannheimer, B; Pettersson, H; von Bahr, C	1
Clement, HW; Heiser, P; Hemmeter, UM; Krieg, JC; Schmidt, AJ; Schulz, E; Vedder, H	1
Lublin, HK; Maknyte, K	1
Aravagiri, M; Bies, RR; Coley, K; Feng, Y; Kirshner, M; Marder, S; Miller, D; Pollock, BG; Schneider, L	1
Klein, MT; Knight, JA; Smith, C; Teitler, M; Toohey, N	2
Chen, CC; Chiu, CC; Huang, MC; Pan, CH; Peng, PW; Tsai, CJ	1
Azaroual, N; Brunel, A; Danel, C; Lannoy, D; Odou, P; Vaccher, C; Vermeersch, G	1
Friberg, LE; Karlsson, MO; Petersson, KJ; Vermeulen, AM	1
Cabré, F; Cánovas, M; Cebrecos, J; Delgadillo, J; Pelagio, P; Riba, N; Torres, F	1
Graff-Guerrero, A; Kapur, S; Mamo, DC; Mulsant, BH; Pollock, BG; Uchida, H	1
Marchese, G; Pani, L	1
Charles, B; Dean, AJ; Jones, T; McDermott, BM; Norris, R; Van Breda, K	1
Chino, B; Kosaki, K; Mizuno, M; Sakuma, K; Sato, Y; Takao, T; Takebayashi, T; Yagihashi, T	1
Che, R; Du, J; Feng, G; Gu, N; He, L; Li, X; Lin, Z; Wang, L; Xing, Q; Xuan, J; Yu, L; Zhang, A	1
Cho, HK; Han, C; Jung, BJ; Jung, SM; Kang, RH; Kim, KA; Kim, SH; Kim, YK; Lee, DK; Lee, MS; Park, JY	1
Chen, CH; Chiu, CC; Huang, MC; Lai, YC; Pan, CH; Tsai, CJ	1
Furukori, H; Kaneko, S; Kondo, T; Nakagami, T; Saito, M; Suzuki, A; Yasui-Furukori, N	1
Klein, MT; Knight, J; Smith, C; Teitler, M; Toohey, N	1
De Rossi, P; Girardi, P; Kotzalidis, GD; Lionetto, L; Lostia, AM; Mazzarini, L; Pacchiarotti, I; Sani, G; Sanna, L; Simmaco, M; Tatarelli, R	1
Grabnar, I; Locatelli, I; Mrhar, A	1
Mühe, A; Neels, H; Schneider, S; Sibille, E; Wennig, R; Yegles, M	1
Casu, G; Deriu, A; Lazzari, P; Marchese, G; Pani, L; Peddio, G; Pira, M; Pisu, C; Pittau, B; Portesani, F; Spada, GP	1
Berwaerts, J; Boom, S; Cleton, A; Eerdekens, M; Janssens, L; Kramer, M; Remmerie, B; Rossenu, S; Talluri, K	1
Arakawa, R; Ito, H; Kodaka, F; Miyoshi, M; Okumura, M; Otsuka, T; Suhara, T; Takahashi, H; Takano, H	1
Hendset, M; Hermann, M; Molden, E; Refsum, H	1
Elliott, ES; Nelson, LA; Purvis, TL; Sommi, RW	1
Gründer, G; Orfanos, S; Paulzen, M	1
Alphs, L; Awad, AG; Canuso, CM; Damaraju, CV; Grinspan, A; Kalali, A; Merriman, U	1
Cui, YM; Duan, JL; Xiang, Q; Zhao, X; Zhou, Y	1
Burger, R; Fegert, J; Gerlach, M; Klampfl, K; Mehler-Wex, C; Pfuhlmann, B; Preuss, A; Rothenhöfer, S; Taurines, R; Wewetzer, Ch	1
Bader, W; Gründer, G; Haen, E; Hiemke, C; Nazirizadeh, Y; Paulzen, M; Pfuhlmann, B; Schwarz, M; Vogel, F; Zernig, G	1
Baldi, ML; Cerveri, G; De Gaspari, IF; Mauri, MC; Mencacci, C; Papa, P; Rolandi, ML; Volonteri, LS	1
Božina, N; Jakovljević, M; Jovanović, N; Lovrić, M; Medved, V; Peleš, AM	1
Fukui, N; Inoue, Y; Ono, S; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J	1
Li, Y; Meng, Q; Su, Z; Sui, C; Sun, F; Teng, L; Yuan, L; Zhang, C	1
Hopkins, T; Nasrallah, HA; Pixley, SK	1
D'Souza, DC; Kane, JM; Keefe, RS; Patkar, AA; Tiller, JM; Yang, R; Youakim, JM	1
Atallah, AN; Melnik, T; Puga, ME; Soares, BG	1
Alphs, L; Gopal, S; Karcher, K; Kent, J; Kushner, S; Nuamah, I; Singh, J; Sliwa, JK	1
Bourcier, E; Brovedani, S; Lancelin, F; Le Masson, V; Lemeille, Y; Paubel, P; Piketty, ML	1
Gassmann-Mayer, C; Gopal, S; Hough, D; Lane, R; Pandina, G; Remmerie, B; Simpson, G	1
Anyama, NG; Bies, RR; Lieberman, JA; Marder, SR; Pollock, BG; Schneider, LS; Wessels, AM	1
Belotto, KC; Ferreira, AS; Gattaz, WF; Raposo, NR	1
Boncompagni, G; Lateana, D; Mandrioli, R; Mercolini, L; Raggi, MA	1
Boonleang, J; Mahatthanatrakul, W; Pipatrattanaseree, W; Tanthana, C	1
Bossie, CA; Canuso, CM; Lindenmayer, JP; Schooler, N; Turkoz, I	1
Gu, N; Li, H; Ning, X; Rui, Q; Xu, H	1
Alves, I; Nuss, P; Salgado, GF; Staneva, G; Tessier, C	1
Dumontet, J; Ensom, MH; Seto, K	1
Ahlbrand, R; Bronson, SL; Horn, P; McNamara, RK; Richtand, NM; Stanford, K	1
Cho, HY; Kang, HA; Lee, IK; Lee, SN; Lee, YB; Yoo, HD	1
Cole-Strauss, A; Jandacek, R; Lipton, JW; McNamara, RK; Rider, T; Tso, P	1
Calarge, CA; Miller, del D	1
Boonleang, J; Mahatthanatrakul, W; Pipatrattanaseree, W; Ridtitid, W; Rujimamahasan, N; Sriwiriyajan, S; Wongnawa, M	1
Andel, R; Becker, MA; Boaz, TL; Chandler, K; Desmarais, SL; Howe, A; Van Dorn, RA	1
Cai, HL; Li, HD; Li, LF; Zhang, J; Zhu, RH	1
Ahlbrand, R; Bronson, SL; Gudelsky, G; Kern, JR; Richtand, NM; Roenker, NL; Waterman, H	1
Alphs, L; Bossie, CA; Ma, YW; Sliwa, JK	1
Eerdekens, M; Fleischhacker, WW; Gassmann-Mayer, C; Gopal, S; Hough, D; Lane, R; Lim, P; Remmerie, B	1
Fujii, A; Kaneko, S; Nakagami, T; Saito, M; Sugawara, N; Tsuchimine, S; Yasui-Furukori, N	1
Bernardo, M; Gassó, P; Lafuente, A; Mas, S; Molina, O; Parellada, E	1
Albuquerque, NC; Borges, KB; Calixto, LA; de Gaitani, CM; de Jesus, LI; de Oliveira, AR; Furtado, NA; Pupo, MT; Simões, RA	1
Liang, CS; Yang, FW	1
Fukui, N; Inoue, Y; Ono, S; Saito, M; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J	2
DiCrescento, S; Perry, R; Wolberg, J	1
Mori, T	1
Howell, LL; Muly, EC; Ritchie, J; Votaw, JR	1
Lane, HY; Teng, PR	1
Singh, D; Williams, O	1
Bies, RR; Mamo, DC; Mimura, M; Pollock, BG; Suzuki, T; Tsunoda, K; Uchida, H; Watanabe, K	1
Danhof, M; de Greef, R; Grimwood, S; Groothuis, GM; Johnson, M; Kozielska, M; Li, C; Pilla Reddy, V; Proost, JH; Vermeulen, A	1
Knoepflmacher, D; Shapley, L; Turner, EH	1
Martin, M; McGuire, A; Mehnert, A; Nicholl, D; Pudas, H	1
Chung, TS; Lung, FW	1
Bowskill, SV; Fisher, DS; Flanagan, RJ; Handley, SA; Patel, MX	1
Chung, YC; Kim, MG; Oh, KY; Park, MS; Park, TW; Yang, JC; Yoon, KS	1
Cho, HY; Lee, SN; Lee, YB; Yoo, HD; Yoon, H	1
Citrome, L	1
Haga, T; Hashizume, T; Inoue, T; Katsumata, T; Ogawa, Y; Osada, K; Sogame, Y; Tagawa, M; Taguchi, A; Watanabe, T; Yabuki, M; Yamaguchi, N	1
Nussbaum, AM; Stroup, TS	1
Bae, KY; Chung, YC; Kim, JM; Kim, SW; Kim, SY; Lee, JH; Lee, YH; Shin, IS; Yoon, JS	1
Bocato, MZ; Calixto, LA; de Gaitani, CM; de Oliveira, AR; Pupo, MT; Simões, RA	1
Doran, AC; Mancuso, JY; Osgood, SM; Shaffer, CL	1
Aman, MG; Bies, RR; Saldaña, SN; Sherwin, CM; Vinks, AA	1
Den, R; Hirano, J; Ikai, S; Mamo, D; Mimura, M; Nishimoto, M; Remington, G; Suzuki, T; Takeuchi, H; Tsuboi, T; Tsunoda, K; Uchida, H; Watanabe, K	1
Druitt, T; Dunsdon, J; Purushothaman, S; Raj, V	1
Butzbach, DM; Byard, RW; Kobus, HJ; Lokan, RJ; Sims, DN; Stockham, PC; Walker, GS	1
Kandasamy, A	1
Baandrup, L; Glenthoj, B; Jennum, P; Lublin, H	1
Chae, SW; Choi, JM; Lee, HJ; Lee, KS; Park, JH; Rhie, SJ	1
Franch, J; Labad, J; López, X; Monseny, R; Montalvo, I; Ortega, L; Solé, M; Vilella, E	1
Boot, AM; Buitelaar, JK; Roke, Y; Tenback, D; van Harten, PN	1
Andrade, C; Suresh Kumar, PN	1
Carano, A; Cavuto, M; De Berardis, D; Di Giannantonio, M; Fornaro, M; Iasevoli, F; Lang, AP; Marini, S; Martinotti, G; Mazza, M; Perna, G; Piersanti, M; Valchera, A	1
Campistol, J; Darling, A; Perez-Duenas, B; Poo, P	1
Baseman, A; Berlin, JA; Gopal, S; Hough, D; Karcher, K; Kent, J; Nuamah, I; Palumbo, J; Xu, Y	1
Gen, K; Hibino, H; Inoue, Y; Matsumoto, H; Mikami, A; Mikami, K; Otomo, M; Suzuki, H	2
Alphs, L; Bossie, CA; Fu, DJ; Kern Sliwa, J; Ma, YW	2
Couchman, L; Fisher, DS; Flanagan, RJ; Handley, SA; Morgan, PE; Partridge, SJ	1
Kirk Morton, N; Zubek, D	1
Fisher, DS; Flanagan, RJ; Handley, SA; Partridge, SJ	1
Medvedovici, A; Rădulescu, FŞ; Ranetti, AE; Voicu, V	1
Fukui, N; Ono, S; Saito, M; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J	1
Sakai, A; Sanjo, K; Takeuchi, K	1
Ahn, YM; Chang, SM; Joo, EJ; Kim, EY; Kim, JJ; Kim, YS; Shim, JC	1
Einarson, TR; Garg, M; Hemels, ME; Skoupá, J; Veselá, S; Zilbershtein, R	1
Berg, KA; Chavera, TA; Clarke, WP; Silva, M; Sullivan, LC	1
Einarson, TR; Hemels, ME; Jensen, R; Piwko, C; Pudas, H; Vicente, C; Zilbershtein, R	1
Boot, AM; Buitelaar, JK; Franke, B; Galesloot, TE; Roke, Y; van Harten, PN	1
Fudala, PJ; Gomeni, R; Heidbreder, C; Nasser, AF	1
D'Souza, S; DeLuca, P; Faraj, J	1
Gen, K; Hibino, H; Inoue, Y; Matsumoto, H; Mikami, A; Mikami, K; Suzuki, H	2
Alphs, L; Bossie, CA; Fu, DJ; Ma, YW; Sliwa, JK	1
Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L	1
Kmietowicz, Z	1
Bø, CN; Einarson, TR; Hemels, ME; Jensen, R; Piwko, C; Pudas, H; Vicente, C; Zilbershtein, R	1
Aboul-Fotouh, S; Elgayar, N	1
Appolinário, JC; Bressan, RA; Campos, JA; de Oliveira, IR; Elkis, H; Gattaz, WF; Grabowski, HM; Henna, E; Lacerda, AL; Lawson, FL; Louzã, MR; Périco, Cde A; Quevedo, J; Rocha, FL; Ruschel, SI; Sacomani, E; Zorzetto Filho, D	1
Kwak, KH; Lee, SJ; Lim, MS; Seong, SJ; Yang, DS; Yoon, YR	1
Fudala, PJ; Gomeni, R; Heidbreder, C; Laffont, CM; Nasser, AF; Zheng, B	2
Jayathilake, K; Johnson, R; Kwentus, J; Lindenmayer, JP; Meltzer, HY; Share, DB	1
Hou, YC; Lai, CH	1
Barton, HA; Danhof, M; de Greef, R; Grimwood, S; Groothuis, GM; Johnson, M; Kozielska, M; Pilla Reddy, V; Proost, JH; Vermeulen, A	1
Chen, KP; Lung, FW; Yang, MC	1
Budman, CL	1
Morrissette, DA; Stahl, SM	1
Bossie, C; Burón, JA; Fu, DJ; Gopal, S; Hough, D; Nuamah, I; Savitz, A; Xu, H	1
Bergmans, P; Bez, Y; Carpiniello, B; Cherubin, P; Hargarter, L; Keim, S; Parellada, E; Rancans, E; Schreiner, A; Vidailhet, P	1
Alphs, L; Hough, D; Ryan, PB; Stang, PE; Voss, EA	1
Corena-McLeod, M	1
Glinka, A; Polak, S	1
Bergmans, P; Cherubin, P; Corrivetti, G; Cosar, B; Hargarter, L; Keim, S; Llorca, PM; Petralia, A; Schreiner, A	1
Marcelin, JR; Ramar, K; Sohail, R; Tan, EM	1
Ramanathan, M; Siva Selva Kumar, M	1
Choong, E; Conus, P; Csajka, C; Eap, CB; Guidi, M; Vandenberghe, F; von Gunten, A	1
Bies, RR; Caravaggio, F; Gerretsen, P; Graff-Guerrero, A; Mamo, DC; Mar, W; Mulsant, BH; Nakajima, S; Plitman, E; Pollock, BG; Suzuki, T; Uchida, H	1
Bereza, BG; Einarson, TR; Goswami, P; Pudas, H; van Impe, K	1
Eliasson, E; Haslemo, T; Lindh, JD; Mannheimer, B; Molden, E	1
Chen, HM; Chern, Y; Kao, YH; Lin, CJ; Yang, HT	1
Beillat, M; Robinson, P; Sapin, C; Tempest, M; Treur, M	1
Chamnanphon, M; Hongkaew, Y; Limsila, P; Medhasi, S; Ngamsamut, N; Puangpetch, A; Sukasem, C; Tan-Kam, T; Vanwong, N	1
Hammarlund-Udenaes, M; Jansson, B; König, F; Loryan, I; Melander, E; Payan, M; Svensson, M	1
Fabbri, C; Kato, M; Kinoshita, T; Koshikawa, Y; Nishida, K; Onohara, A; Sakai, S; Serretti, A; Sunada, N; Takekita, Y; Yoshimura, M	2
Akkoca, Y; Bahsi, R; Filik, L; Saglam, O	1
Chamkrachangpada, B; Hongkaew, Y; Limsila, P; Ngamsamut, N; Puangpetch, A; Srisawasdi, P; Sukasem, C; Tan-Khum, T; Vanwong, N	1
Guo, Q; Li, C; Ouyang, Q; Qiao, Y; Shen, W; Sheng, J; Wen, H; Yang, F; Zhu, S	1
Casado, MA; Cuervo-Arango, I; García, I; González, B; Oyagüez, I; Quintero, J	1
Deng, C; Ji, S; Li, A; Li, L; Li, X; Lu, W; Shang, D; Wang, C; Wu, K; Zhou, T	1
Kang, SG; Kim, W; Lee, BH; Lee, HY; Lee, KS; Lee, KY; Lee, SH; Park, YM	1
Bereza, BG; Einarson, TR; Goswami, P; Maia-Lopes, S; Van Impe, K	1
Haslemo, T; Hoff, M; Molden, E; Waade, RB	1
Gründer, G; Haen, E; Lammertz, SE; Paulzen, M; Schoretsanitis, G; Schruers, KR; Stegmann, B; Walther, S	1
Aimoto, M; Hagiwara, M; Kambayashi, R; Nagasawa, Y; Takahara, A	1
Hongkaew, Y; Limsila, P; Nakorn, CN; Ngamsamut, N; Nuntamool, N; Prommas, S; Puangpetch, A; Sukasem, C; Vanwong, N	1
Ariyawansa, J; De Meulder, M; Remmerie, B; Savitz, A	1
De Meulder, M; Remmerie, B; Savitz, A; Weiner, S	1
Gründer, G; Haen, E; Hiemke, C; Lammertz, SE; Paulzen, M; Schoretsanitis, G; Schruers, KR; Stegmann, B; Walther, S	1
Du, B; He, J; Huang, L; Li, L; Liu, F; Liu, Y; Lu, T; Mi, W; Shi, L; Xiao, W; Yue, W; Zhang, H	1
Benson, C; Joshi, K; Pan, X; Wang, R; Yang, E	1
Atake, K; Hori, H; Katsuki, A; Yoshimura, R	1
Alphs, L; Correll, CU; Kim, E; Mao, L; Starr, HL	1
Ikai, S; Mimura, M; Suzuki, T; Uchida, H	1
Anton-Rodriguez, JM; Conen, S; Drake, RJ; Gerhard, A; Gregory, CJ; Hinz, R; Holmes, SE; Matthews, JC; Talbot, PS	1
Watanabe, T; Yamada, A	1
Dzahini, O; O'Hagan, M; Sparshatt, A; Taylor, DM	1
Gründer, G; Haen, E; Hiemke, C; Lammertz, SE; Paulzen, M; Schoretsanitis, G; Schruers, KR; Stegmann, B	1
Bergmans, P; Caspi, A; Cherubin, P; Hargarter, L; Keim, S; Lara, E; Pinchuk, I; Schreiner, A; Schuepbach, D; Suleman, S	1
Bellanti, F; Cristea, S; de Lange, EC; den Hoedt, SM; Geuer, JK; Hartman, R; Mangas-Sanjuan, V; Shimizu, S; van den Berg, DJ	1
Gründer, G; Haen, E; Hiemke, C; Paulzen, M; Schoretsanitis, G; Stegmann, B	1
Gobburu, JVS; Gopalakrishnan, M; Heidbreder, C; Ivaturi, V; Laffont, CM; Liu, Y; Zhang, W	1
Gründer, G; Haen, E; Hiemke, C; Lammertz, SE; Paulzen, M; Schoretsanitis, G; Stegmann, B	1
Choi, BH; Choi, JS; Hahn, SJ; Lee, HJ	1
Bonse, A; Hempel, G; Lingg, R; Oberfeld, S; Telger, K; Weber, J	1
Bieńkowski, P; Heitzman, J; Jarema, M; Parnowski, T; Rybakowski, J	1
De Vos, C; Decuypere, F; Denee, TR; Geerts, P; Lamotte, M; Malfait, B; Mulder, CL; Sermon, J	1
Green, B; Korell, J; Remmerie, B; Vermeulen, A	1
de Leon, J; Hiemke, C; Schoretsanitis, G; Spina, E	2
Brenner, R; Kaur, K; Madhusoodanan, S; Santos, M	1
Bereza, BG; Denee, TR; Dries, PJT; Einarson, TR; Tedouri, F; Van Impe, K	1
Emond, B; Joshi, K; Kamstra, R; Lafeuille, MH; Lefebvre, P; Pilon, D; Tandon, N	1
Danhof, M; De Lange, ECM; Huntjens, DRH; Proost, JH; Taneja, A; Vermeulen, A	1
Belhadi, D; Bouju, S; Comet, D; Guillon, P; Limosin, F; Pacou, M; Van Impe, K	1
Biondi, DM; Joshi, K; Mao, L; Millet, R	1
Baeza, I; de Castro, C; Espinosa, L; Fortea, A; Ilzarbe, D; Oriolo, G; Solerdelcoll, M; Sugranyes, G	1
Guo, DS; Guo, YS; Ji, WH; Wang, X	1
de Leon, J; Guo, GX; Guo, W; Li, WB; Ruan, CJ; Wang, CY; Zhou, M	1
Hibino, H; Inoue, Y; Suzuki, H; Takaya, A	4
Tagne Nouemssi, AB	1
Augusto, M; Greene, M; Sweeney, SM; Touya, M; Waters, H	1
Gopal, S; Kern Sliwa, J; Kim, E; Mathews, M; Ravenstijn, P; Russu, A; Singh, A	1
Alphs, L; Gopal, S; Hough, D; Mathews, M; Nuamah, I; Pei, H; Savitz, A	1
de Leon, J; Diaz, FJ; Schoretsanitis, G	1
Broder, MS; Chang, E; Greene, M; Touya, M; Yan, T	1
Chen, C; Chen, GD; Chen, XS; Huang, ZY; Lin, CG; Lin, XD; Lin, ZG; Wu, RQ; Xu, DL; Zhang, LJ; Zhang, MD; Zhang, W	1
de Leon, J; Schoretsanitis, G; Villasante-Tezanos, AG	1
Brakoulias, V; Stockings, E	1
Chen, KP; Chen, YL; Chiu, CC; Lung, FW; Tai, MH	1
Aguirre, C; Erezuma, I; Garcia, M; Hernandez, R; Lertxundi, U; Medrano, J	1
Deckert, J; Hommers, LG; Menke, A; Samanski, L; Scherf-Clavel, M; Unterecker, S	1
Hasegawa, M; Ichikawa, D; Suzuki, A; Wakuda, T; Yamasue, H	1
Centanni, M; de Lange, ECM; Wong, YC	1
Gačo, N; Graovac, M; Kaštelan, A; Petrić, D; Rački, V	1
Iyo, M; Kanahara, N; Nakamura, M; Oda, Y; Watanabe, M; Yoshimura, K	1
Brouillette, M; El Khoury, AC; Joshi, K; Smith, D; Song, X	1
Baymeeva, NV; Kaleda, VG; Miroshnichenko, II; Platova, AI	1
de Leon, J	2
Ansolabehere, X; Guillon, P; Harmand, S	1
Hatano, M; Inagaki, R; Kamei, H; Taniguchi, M; Yamada, S	1
Abad-Santos, F; Hempel, G; Kneller, LA	1
Cho, SW; Choi, G; Joo, SW; Koh, M; Lee, J; Shon, SH	1
Horvitz-Lennon, M; Normand, ST; Spertus, J	1
Augustin, M; Gründer, G; Gründer, P; Paulzen, M	1
Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S	1
Rojo-Moreno, J; Rojo-Valdemoro, C; Santolaya-Ochando, F	1
Broder, MS; Chang, E; Greene, M; Houle, CR; Tarbox, MH; Waters, HC; Yan, T	1
Coplan, BM; McGuire, PR; Puri, S	1
Hempel, G; Kneller, LA	1
Fan, G; Fan, X; Jiang, J; Li, J; Lou, Y; Wang, J; Wang, S; Wu, S	1
Carlone, D; Delva, N	1
Bartelds, B; de Kroon, MMJ; de Winter, BCM; Dieleman, GC; Dierckx, B; Ester, WA; Hillegers, MHJ; Kloosterboer, SM; Koch, BCP; Kouijzer, MEJ; Nasserinejad, K; Reichart, CG; Rieken, R; van Altena, D; van Daalen, E; van Gelder, T; van Schaik, RHN	1
Khorassani, F; Lopez, LV; Sousonis, F	1
Berezantsev, AY; Burygina, LA; Levin, ME	1
Claro, A; Corte-Real, F; Franco, J; Monteiro, C; Mustra, C; Proença, P	1
Klein, B; Silberbauer, C	1
Egberts, K; Fekete, S; Gerlach, M; Kittel-Schneider, S; Romanos, M; Scherf-Clavel, M; Unterecker, S	1
Barr, AM; Boyda, HN; Honer, WG; Procyshyn, RM; Tse, L; Yuen, JWY	1
Fu, K; He, Y; Jiang, W; Liu, W; Lu, J; Wang, Z; Wu, R; Xu, Y; Yan, Y; Yang, Y; Zhao, J	1
Arnaiz, A; Arrue, A; Basterreche, N; Erkoreka, L; González-Torres, MA; Olivas, O; Zamalloa, MI; Zumárraga, M	1
Boels, D; Citterio-Quentin, A; Jolliet, P; Mahé, J; Moragny, J; Olry, A	1
Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G	1
Gaedigk, A; Hongkaew, Y; Kittitharaphan, W; Limsila, P; Ngamsamut, N; Sukasem, C; Wilffert, B	1
Shimoda, K; Shinozaki, M; Sugawara, N; Tasaki, M; Yasui-Furukori, N; Yokoyama, S	1
Kyziridis, TC	1
Heneghan, C; Hodkinson, A; Kontopantelis, E; Mahtani, KR; Panagioti, M	1
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K	1
Hibino, H; Suzuki, H	1
Dagenais-Beaulé, V	1
Elgart, A; Gomeni, R; Harary, E; Kalmanczhelyi, A; Lamson, M; Levi, M; Loupe, P; Merenlender Wagner, A; Perlstein, I; Spiegelstein, O; Tiver, R	1
Burger, R; Egberts, KM; Fekete, S; Gerlach, M; Plener, P; Preuss-Wiedenhoff, A; Romanos, M; Taurines, R; Warnke, A; Wewetzer, C	1
Barr, AM; Cázares, D; Honer, WG; Kim, DD; Lian, L; Procyshyn, RM	1
Borgmeier, V; Cai, R; Chevalier, P; Decuypere, F; Desseilles, M; Fakra, E; Godet, A; Guillon, P; Lambert, M; Pype, S; Wimmer, A	1
Byeon, SJ; Chung, SJ; Oh, S	1
Beck, M; Gitahy Falcao Faria, C; Javelot, H; Meyer, G; Michel, B; Riutort, M	1
Osman, E; Yıldız, M	1
Arango, C; Leucht, S; Lopez-Morinigo, JD	1
Fujii, Y; Misawa, F; Takeuchi, H	1
Aguayo, R; Álvarez, A; Barbero, JD; Gabernet, R; González-Rodríguez, A; Izquierdo, E; Labad, J; Merodio, I; Monreal, JA; Montalvo, I; Palao, D; Tost, M	1
Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J	1
Anam, A; Gekhman, D; Lynch, S; Mosharraf, N; Soukas, C	1
Fujioka, K; Fujiwara, N; Horai, T; Iijima, K; Imafuku, H; Ito, T; Mahdy, WYB; Omura, T; Otsuka, I; Yamamoto, K; Yano, I	1
Baeza, I; Fortea, A; Ilzarbe, D; Sugranyes, G	1
Akazawa, M; Inada, K; Okada, Y	1
Anand, ST; Davis, CR; Ferguson, RE; Hau, C; Kurtz, SG; Pontzer, JF; Rosenheck, R; Smedberg, D	1
Correll, CU; Hieronymus, F; Østergaard, SD	1
Allott, K; Alvarez-Jimenez, M; Baldwin, L; Berk, M; Brown, E; Chopra, S; Fornito, A; Francey, SM; Graham, J; Harrigan, S; Kerr, MJ; McGorry, PD; Nelson, B; O'Donoghue, B; Pantelis, C; Proffitt, TM; Ratheesh, A; Thompson, AD; Wood, SJ; Yuen, HP	1
Dai, G; Geng, L; Gu, H; Teng, Z; Xu, W	1
Chen, Q; Min, J; Shen, Y; Shu, M; Xia, W; Yin, H	1
Cheung, H; Dima, A; Dzahini, O; Oloyede, E; Shergill, S; Taylor, D; Whiskey, E	1

Reviews

37 review(s) available for risperidone and paliperidone palmitate

Article	Year
Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability. Clinical therapeutics, 2007, Volume: 29, Issue:2 Topics: Administration, Oral; Adult; Antipsychotic Agents; Chemistry, Pharmaceutical; Clinical Trials, Phase I as Topic; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Patient Compliance; Patient Satisfaction; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Solubility; Tablets; Taste; Therapeutic Equivalency	2007
Forty years of antipsychotic Drug research--from haloperidol to paliperidone--with Dr. Paul Janssen. Arzneimittel-Forschung, 2007, Volume: 57, Issue:10 Topics: Antipsychotic Agents; Haloperidol; History, 20th Century; History, 21st Century; Humans; Isoxazoles; Paliperidone Palmitate; Pimozide; Psychotic Disorders; Pyrimidines; Risperidone; Structure-Activity Relationship	2007
Paliperidone for schizophrenia. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Mar-01, Volume: 65, Issue:5 Topics: Antipsychotic Agents; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Drug Interactions; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia	2008
Paliperidone for schizophrenia. The Cochrane database of systematic reviews, 2008, Apr-16, Issue:2 Topics: Antipsychotic Agents; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia	2008
Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release. Expert opinion on drug delivery, 2009, Volume: 6, Issue:3 Topics: Antipsychotic Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome	2009
Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews. Sao Paulo medical journal = Revista paulista de medicina, 2010, Volume: 128, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Humans; Isoxazoles; Meta-Analysis as Topic; Paliperidone Palmitate; Piperazines; Placebos; Pyrimidines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Review Literature as Topic; Risperidone; Schizophrenia; Treatment Outcome	2010
Risperidone in schizophrenia: is there a role for therapeutic drug monitoring? Therapeutic drug monitoring, 2011, Volume: 33, Issue:3 Topics: Antipsychotic Agents; Drug Monitoring; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia	2011
Oral paliperidone extended-release: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability. Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:7 Topics: Administration, Oral; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Half-Life; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia	2012
Paliperidone palmitate for schizophrenia. The Cochrane database of systematic reviews, 2012, Jun-13, Issue:6 Topics: Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia	2012
Second-generation long-acting injectable antipsychotic agents: an overview. Drug and therapeutics bulletin, 2012, Volume: 50, Issue:9 Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Drug Costs; Humans; Injections; Isoxazoles; Monitoring, Physiologic; Olanzapine; Paliperidone Palmitate; Practice Guidelines as Topic; Pyrimidines; Risperidone; Schizophrenia	2012
Treatment options for residual insomnia in schizophrenia. Acta psychiatrica Scandinavica, 2013, Volume: 127, Issue:1 Topics: Antipsychotic Agents; Central Nervous System Depressants; Humans; Isoxazoles; Melatonin; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Sleep Initiation and Maintenance Disorders	2013
Efficacy and safety of long acting injectable atypical antipsychotics: a review. Current clinical pharmacology, 2013, Volume: 8, Issue:3 Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Drug Delivery Systems; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia	2013
[Medication-related oculogyric crises: a description of four cases and a review of the literature]. Revista de neurologia, 2013, Feb-01, Volume: 56, Issue:3 Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid	2013
Risk of cardiovascular morbidity with risperidone or paliperidone treatment: analysis of 64 randomized, double-blind trials. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:2 Topics: Antipsychotic Agents; Cardiovascular Diseases; Databases, Factual; Drug Labeling; Humans; Incidence; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Randomized Controlled Trials as Topic; Risk; Risperidone	2013
Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences. Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:8 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Blood-Brain Barrier; Humans; Hyperprolactinemia; Isoxazoles; Paliperidone Palmitate; Piperazines; Prolactin; Pyrimidines; Quinolones; Receptors, Dopamine D2; Risperidone; Stress, Psychological; Sulpiride; Xenobiotics	2013
[Paliperidone, risperidone]. Nihon rinsho. Japanese journal of clinical medicine, 2013, Volume: 71, Issue:4 Topics: Antipsychotic Agents; Humans; Isoxazoles; Japan; Paliperidone Palmitate; Pyrimidines; Receptor, Serotonin, 5-HT2A; Risperidone; Schizophrenia; Treatment Outcome	2013
The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview. Drugs, 2014, Volume: 74, Issue:11 Topics: Antipsychotic Agents; Aripiprazole; Clinical Trials as Topic; Humans; Isoxazoles; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Tourette Syndrome; Treatment Outcome	2014
Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy. CNS spectrums, 2014, Volume: 19, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Dibenzocycloheptenes; Drug Therapy, Combination; Heterocyclic Compounds, 4 or More Rings; Humans; Impulsive Behavior; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Thiazoles; Violence	2014
Comparative Pharmacology of Risperidone and Paliperidone. Drugs in R&D, 2015, Volume: 15, Issue:2 Topics: Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Humans; Paliperidone Palmitate; Risperidone	2015
Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia. Psychiatria polska, 2017, Feb-26, Volume: 51, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Male; Olanzapine; Paliperidone Palmitate; Risperidone; Schizophrenia	2017
A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone. Expert review of clinical pharmacology, 2017, Volume: 10, Issue:9 Topics: Administration, Oral; Animals; Antipsychotic Agents; Delayed-Action Preparations; Drug Monitoring; Humans; Injections; Microspheres; Paliperidone Palmitate; Risperidone	2017
Psychiatric symptoms associated with porphyria: A case report and brief review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2017, Volume: 29, Issue:3 Topics: Adult; Antipsychotic Agents; Hispanic or Latino; Humans; Male; Paliperidone Palmitate; Porphyrias; Psychotic Disorders; Risperidone	2017
A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidone. Expert review of clinical pharmacology, 2018, Volume: 11, Issue:6 Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Area Under Curve; Biological Availability; Delayed-Action Preparations; Drug Interactions; Drug Monitoring; Humans; Paliperidone Palmitate; Risperidone	2018
A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorder. Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Obsessive-Compulsive Disorder; Paliperidone Palmitate; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2019
Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics. Neuropharmacology, 2020, 05-15, Volume: 168 Topics: Antipsychotic Agents; Clozapine; Drug Administration Routes; Drug Monitoring; Humans; Paliperidone Palmitate; Pharmacogenetics; Precision Medicine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia	2020
Bayesian Meta-analysis of Multiple Continuous Treatments with Individual Participant-Level Data: An Application to Antipsychotic Drugs. Medical decision making : an international journal of the Society for Medical Decision Making, 2019, Volume: 39, Issue:5 Topics: Adult; Antipsychotic Agents; Bayes Theorem; Dose-Response Relationship, Drug; Female; Humans; Male; Markov Chains; Medication Adherence; Middle Aged; Olanzapine; Paliperidone Palmitate; Risperidone; Schizophrenia; Weight Gain	2019
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia. The American journal of psychiatry, 2020, 04-01, Volume: 177, Issue:4 Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes	2020
Risperidone- and paliperidone-induced hepatotoxicity: Case report and review of literature. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020, 09-18, Volume: 77, Issue:19 Topics: Adult; Antipsychotic Agents; Hospitalization; Humans; Male; Paliperidone Palmitate; Risperidone; Schizophrenia; Young Adult	2020
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis. The American journal of psychiatry, 2021, 05-01, Volume: 178, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention	2021
[Clinical pharmacokinetics and pharmaceutical forms of long-acting injectable antipsychotics]. Psychiatrike = Psychiatriki, 2022, Jun-10, Volume: 33, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Humans; Olanzapine; Paliperidone Palmitate; Risperidone	2022
Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports. BMC medicine, 2021, 08-25, Volume: 19, Issue:1 Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Male; Paliperidone Palmitate; Risperidone; Schizophrenia	2021
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials. Molecular psychiatry, 2022, Volume: 27, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid	2022
Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review. PloS one, 2022, Volume: 17, Issue:4 Topics: Antipsychotic Agents; Cohort Studies; Delayed-Action Preparations; Humans; Paliperidone Palmitate; Psychotic Disorders; Risperidone	2022
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs. Pharmacopsychiatry, 2022, Volume: 55, Issue:5 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Haloperidol; Humans; Lurasidone Hydrochloride; Molindone; Olanzapine; Paliperidone Palmitate; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Systematic Reviews as Topic	2022
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years. Psychopharmacology, 2022, Volume: 239, Issue:10 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid	2022
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review. Paediatric drugs, 2023, Volume: 25, Issue:2 Topics: Adolescent; Adult; Antipsychotic Agents; Child; Delayed-Action Preparations; Humans; Paliperidone Palmitate; Prospective Studies; Retrospective Studies; Risperidone; Schizophrenia	2023
Clozapine augmentation with long-acting antipsychotic injections: A case series and systematic review. Acta psychiatrica Scandinavica, 2023, Volume: 148, Issue:6 Topics: Antipsychotic Agents; Clozapine; Delayed-Action Preparations; Humans; Paliperidone Palmitate; Risperidone; Schizophrenia	2023

Trials

75 trial(s) available for risperidone and paliperidone palmitate

Article	Year
Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by a high performance liquid chromatography with electrochemical detection. Pharmacopsychiatry, 1998, Volume: 31, Issue:3 Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia	1998
Serum concentrations and side effects in psychiatric patients during risperidone therapy. Therapeutic drug monitoring, 1998, Volume: 20, Issue:4 Topics: Adult; Aged; Antipsychotic Agents; Cross-Sectional Studies; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Genotype; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotropic Drugs; Pyrimidines; Risperidone	1998
Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone. Psychopharmacology, 1999, Volume: 147, Issue:3 Topics: Adult; Alleles; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Pyrimidines; Risperidone; Schizophrenia	1999
Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 10, Issue:1 Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depression; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Isoxazoles; Male; Mianserin; Middle Aged; Mirtazapine; Paliperidone Palmitate; Pilot Projects; Psychotic Disorders; Pyrimidines; Risperidone; Severity of Illness Index; Treatment Outcome	1999
Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia. Journal of pharmaceutical and biomedical analysis, 1999, Volume: 19, Issue:3-4 Topics: Adult; Aged; Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Monitoring; Female; Humans; Isoxazoles; Japan; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Schizophrenia; Sensitivity and Specificity	1999
Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:3 Topics: Acute Disease; Adult; Antipsychotic Agents; Asian People; Drug Administration Schedule; Female; Hospitalization; Humans; Isoxazoles; Male; Paliperidone Palmitate; Patient Readmission; Pharmacogenetics; Prospective Studies; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Taiwan; Treatment Outcome	2000
Effect of risperidone on plasma free 3-methoxy-4-hydroxyphenylglycol (pMHPG) levels in schizophrenic patients: relationship among plasma concentrations of risperidone and 9-hydroxyrisperidone, pMHPG levels, and clinical improvement. International clinical psychopharmacology, 2000, Volume: 15, Issue:3 Topics: Adolescent; Adult; Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Serotonin Antagonists; Treatment Outcome	2000
Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia. Psychopharmacology, 2001, Jan-01, Volume: 153, Issue:2 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chromatography, High Pressure Liquid; Chronic Disease; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology	2001
Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together. Journal of clinical pharmacology, 2002, Volume: 42, Issue:12 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Area Under Curve; Biological Availability; Cholinesterase Inhibitors; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Female; Galantamine; Gas Chromatography-Mass Spectrometry; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Time Factors	2002
Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers. Clinical therapeutics, 2003, Volume: 25, Issue:6 Topics: Adult; Antipsychotic Agents; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Female; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Middle Aged; Paliperidone Palmitate; Pyrimidines; Radioimmunoassay; Risperidone; Tablets; Therapeutic Equivalency; Time Factors	2003
Correlation between scores on Continuous Performance Test and plasma concentration for schizophrenic patients on risperidone. Psychiatry and clinical neurosciences, 2004, Volume: 58, Issue:2 Topics: Adult; Antipsychotic Agents; Attention; Brief Psychiatric Rating Scale; Discrimination Learning; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Male; Neurologic Examination; Neuropsychological Tests; Paliperidone Palmitate; Pattern Recognition, Visual; Psychometrics; Psychomotor Performance; Pyrimidines; Reaction Time; Risperidone; Schizophrenia; Schizophrenic Psychology; Statistics as Topic; Treatment Outcome	2004
Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications. Journal of child and adolescent psychopharmacology, 2004,Spring, Volume: 14, Issue:1 Topics: Autistic Disorder; Child; Child, Preschool; Drug Tolerance; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Statistics, Nonparametric; Weight Gain	2004
Plasma risperidone concentrations during combined treatment with sertraline. Therapeutic drug monitoring, 2004, Volume: 26, Issue:4 Topics: Adult; Antipsychotic Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline	2004
Risperidone plasma levels, clinical response and side-effects. European archives of psychiatry and clinical neuroscience, 2005, Volume: 255, Issue:4 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Female; Genotype; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prospective Studies; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia	2005
Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring service. Therapeutic drug monitoring, 2005, Volume: 27, Issue:1 Topics: Administration, Oral; Adult; Aged; Delayed-Action Preparations; Drug Administration Schedule; Drug Monitoring; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia	2005
Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia. The international journal of neuropsychopharmacology, 2005, Volume: 8, Issue:1 Topics: Administration, Oral; Adult; Antipsychotic Agents; Binding, Competitive; Brain; Delayed-Action Preparations; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Image Processing, Computer-Assisted; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Positron-Emission Tomography; Pyrimidines; Radioimmunoassay; Receptors, Dopamine D2; Risperidone; Schizophrenia; Scintillation Counting	2005
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition. Clinical pharmacology and therapeutics, 2005, Volume: 78, Issue:1 Topics: Administration, Oral; Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Chromatography, Liquid; Cross-Over Studies; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Drug Synergism; Genotype; Half-Life; Humans; Immunoenzyme Techniques; Isoxazoles; Japan; Male; Paliperidone Palmitate; Patient Selection; Prolactin; Pyrimidines; Risperidone; Statistics as Topic; Verapamil	2005
Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Schizophrenia	2005
Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients. Clinical pharmacology and therapeutics, 2005, Volume: 78, Issue:5 Topics: Adult; Antifungal Agents; Antipsychotic Agents; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Genotype; Half-Life; Humans; Isoxazoles; Itraconazole; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia	2005
Pharmacokinetics and bioequivalence evaluation of risperidone in healthy male subjects with different CYP2D6 genotypes. Archives of pharmacal research, 2006, Volume: 29, Issue:6 Topics: Administration, Oral; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Genotype; Humans; Isoxazoles; Korea; Male; Paliperidone Palmitate; Polymorphism, Single Nucleotide; Pyrimidines; Risperidone; Solubility; Tablets; Therapeutic Equivalency	2006
Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder. Journal of pharmacokinetics and pharmacodynamics, 2007, Volume: 34, Issue:2 Topics: Acute Disease; Administration, Oral; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Computer Simulation; Cytochrome P-450 CYP2D6; Databases as Topic; Drug Administration Schedule; Female; Humans; Isoxazoles; Linear Models; Male; Middle Aged; Models, Biological; Paliperidone Palmitate; Phenotype; Population Surveillance; Pyrimidines; Reproducibility of Results; Risperidone; Tablets	2007
Prolactin release in children treated with risperidone: impact and role of CYP2D6 metabolism. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:1 Topics: Adolescent; Age Factors; Antipsychotic Agents; Child; Child Development Disorders, Pervasive; Child, Preschool; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Prolactin; Prospective Studies; Pyrimidines; Risperidone	2007
A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels. Pharmacopsychiatry, 2007, Volume: 40, Issue:3 Topics: Adult; Aging; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Female; Humans; Isoxazoles; Linear Models; Male; Middle Aged; Organic Anion Transporters; Paliperidone Palmitate; Pyrimidines; Risperidone; Sex Factors	2007
Lack of bioequivalence between generic risperidone oral solution and originator risperidone tablets. International journal of clinical pharmacology and therapeutics, 2007, Volume: 45, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Confidence Intervals; Cross-Over Studies; Drugs, Generic; Female; Humans; Isoxazoles; Male; Mass Spectrometry; Middle Aged; Paliperidone Palmitate; Pharmaceutical Solutions; Pyrimidines; Risperidone; Tablets; Therapeutic Equivalency	2007
Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders. Clinical therapeutics, 2007, Volume: 29, Issue:7 Topics: Adolescent; Antipsychotic Agents; Area Under Curve; Child; Child, Preschool; Cytochrome P-450 CYP2D6; Developmental Disabilities; Female; Genotype; Half-Life; Humans; Isoxazoles; Male; Mental Disorders; Paliperidone Palmitate; Pyrimidines; Risperidone; Saliva	2007
Effect of rifampin, an inducer of CYP3A and P-glycoprotein, on the pharmacokinetics of risperidone. Journal of clinical pharmacology, 2008, Volume: 48, Issue:1 Topics: Administration, Oral; Adult; Alleles; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Genotype; Half-Life; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Paliperidone Palmitate; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimidines; Rifampin; Risperidone; Time Factors	2008
Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone. International clinical psychopharmacology, 2008, Volume: 23, Issue:4 Topics: Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia	2008
The disparity of pharmacokinetics and prolactin study for risperidone long-acting injection. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6 Topics: Administration, Oral; Adult; Antipsychotic Agents; Female; Humans; Hyperprolactinemia; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Pyrimidines; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology	2008
Bioequivalence evaluation of two strengths of risperidone tablet formulations in healthy volunteers. International journal of clinical pharmacology and therapeutics, 2009, Volume: 47, Issue:2 Topics: Adult; Antipsychotic Agents; Area Under Curve; Chromatography, Liquid; Cross-Over Studies; European Union; Female; Guidelines as Topic; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency; Time Factors; United States; United States Food and Drug Administration; Young Adult	2009
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:7 Topics: Adolescent; Adult; Antipsychotic Agents; Area Under Curve; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypotension, Orthostatic; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Young Adult	2010
Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone. International clinical psychopharmacology, 2010, Volume: 25, Issue:3 Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Patient Satisfaction; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology	2010
Effect of CYP2D6, CYP3A5, and MDR1 genetic polymorphisms on the pharmacokinetics of risperidone and its active moiety. Journal of clinical pharmacology, 2010, Volume: 50, Issue:6 Topics: Adult; Alleles; Antipsychotic Agents; Area Under Curve; Asian People; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Genotype; Humans; Isoxazoles; Male; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Risperidone	2010
Long-acting injectable risperidone and metabolic ratio: a possible index of clinical outcome in treatment-resistant schizophrenic patients. Psychopharmacology, 2010, Volume: 210, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Biomarkers, Pharmacological; Brief Psychiatric Rating Scale; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Severity of Illness Index	2010
Gender differences in the relationship between the risperidone metabolism and the plasma prolactin levels in psychiatric patients. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Oct-01, Volume: 34, Issue:7 Topics: Adult; Aged; Chromatography, Liquid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Paliperidone Palmitate; Prolactin; Pyrimidines; Risperidone; Sex Characteristics; Tandem Mass Spectrometry; Young Adult	2010
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. The Journal of clinical psychiatry, 2010, Volume: 71, Issue:11 Topics: Adult; Antipsychotic Agents; Benzhydryl Compounds; Benzodiazepines; Central Nervous System Stimulants; Cognition Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Modafinil; Olanzapine; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome	2010
A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jan-15, Volume: 35, Issue:1 Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Double-Blind Method; Drug Delivery Systems; Female; Humans; Isoxazoles; Least-Squares Analysis; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Young Adult	2011
Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-Alzheimer's disease trial. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Proportional Hazards Models; Pyrimidines; Risperidone; Time Factors; Treatment Outcome	2010
Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers. Clinical therapeutics, 2010, Volume: 32, Issue:12 Topics: Administration, Oral; Adult; Antipsychotic Agents; Area Under Curve; Biological Availability; Brazil; Chromatography, Liquid; Cross-Over Studies; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Tandem Mass Spectrometry; Therapeutic Equivalency	2010
Relative bioavailability and pharmacokinetic comparison of two 2-mg risperidone tablet formulations: A single dose, randomized-sequence, double-blind, 2-way crossover study in healthy male volunteers in Thailand. Clinical therapeutics, 2010, Volume: 32, Issue:10 Topics: Administration, Oral; Adult; Antipsychotic Agents; Biological Availability; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drugs, Generic; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Tablets; Thailand; Young Adult	2010
A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jun-01, Volume: 35, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Data Interpretation, Statistical; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Dyskinesia, Drug-Induced; Endpoint Determination; Female; Glucose; Heart Diseases; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Prolactin; Psychiatric Status Rating Scales; Risperidone; Sample Size; Schizophrenia; Schizophrenic Psychology; Suicide; Treatment Outcome; Young Adult	2011
Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D610/10. British journal of pharmacology, 2011, Volume: 164, Issue:2b Topics: Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Cytochrome P-450 CYP2D6; Genotype; Humans; Isoxazoles; Male; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Retrospective Studies; Risperidone; Young Adult	2011
Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers. Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:2 Topics: Adult; Antipsychotic Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Half-Life; Humans; Isoxazoles; Ketoconazole; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Tandem Mass Spectrometry; Tissue Distribution; Young Adult	2012
Effects of acute paliperidone palmitate treatment in subjects with schizophrenia recently treated with oral risperidone. Schizophrenia research, 2011, Volume: 132, Issue:1 Topics: Administration, Oral; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome	2011
A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia. The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:1 Topics: Administration, Oral; Adult; Antipsychotic Agents; Buttocks; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Sleep Initiation and Maintenance Disorders; Treatment Outcome; White People	2012
QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone. Human psychopharmacology, 2012, Volume: 27, Issue:1 Topics: Adult; Age Factors; Antipsychotic Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Isoxazoles; Long QT Syndrome; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Young Adult	2012
Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic study. Therapeutic drug monitoring, 2012, Volume: 34, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Male; Middle Aged; Nonlinear Dynamics; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Young Adult	2012
Different impacts of aquaporin 4 and MAOA allele variation among olanzapine, risperidone, and paliperidone in schizophrenia. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:3 Topics: Adult; Antipsychotic Agents; Aquaporin 4; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Female; Genetic Association Studies; Humans; Isoxazoles; Male; Middle Aged; Monoamine Oxidase; Olanzapine; Paliperidone Palmitate; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Smoking; Young Adult	2012
Different safety profiles of risperidone and paliperidone extended-release: a double-blind, placebo-controlled trial with healthy volunteers. Human psychopharmacology, 2012, Volume: 27, Issue:3 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Chi-Square Distribution; Cognition; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Female; Humans; Isoxazoles; Male; Neuropsychological Tests; Pain Measurement; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Substance-Related Disorders; Time Factors	2012
Population pharmacokinetic analysis of risperidone and 9-hydroxyrisperidone with genetic polymorphisms of CYP2D6 and ABCB1. Journal of pharmacokinetics and pharmacodynamics, 2012, Volume: 39, Issue:4 Topics: Adult; Alleles; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Cytochrome P-450 CYP2D6; Genotype; Humans; Isoxazoles; Male; Models, Biological; Paliperidone Palmitate; Polymorphism, Single Nucleotide; Pyrimidines; Risperidone; Young Adult	2012
Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial. International clinical psychopharmacology, 2012, Volume: 27, Issue:5 Topics: Adolescent; Adult; Antipsychotic Agents; Cognition Disorders; Delayed-Action Preparations; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Monitoring; Female; Humans; Isoxazoles; Male; Middle Aged; Movement Disorders; Paliperidone Palmitate; Prevalence; Psychiatric Status Rating Scales; Pyrimidines; Republic of Korea; Risperidone; Schizophrenia; Young Adult	2012
Study of the efficacy and safety of switching from risperidone to paliperidone in elderly patients with schizophrenia. Psychiatry and clinical neurosciences, 2013, Volume: 67, Issue:2 Topics: Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Patient Satisfaction; Pyrimidines; Risperidone; Schizophrenia	2013
Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimens. Clinical schizophrenia & related psychoses, 2014, Volume: 8, Issue:2 Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome	2014
Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents. Current medical research and opinion, 2013, Volume: 29, Issue:10 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prospective Studies; Pyrimidines; Risperidone; Schizophrenia; Severity of Illness Index	2013
A model-based approach to characterize the population pharmacokinetics and the relationship between the pharmacokinetic and safety profiles of RBP-7000, a new, long-acting, sustained-released formulation of risperidone. Journal of clinical pharmacology, 2013, Volume: 53, Issue:10 Topics: Adolescent; Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Female; Humans; Injections, Subcutaneous; Isoxazoles; Male; Middle Aged; Models, Biological; Paliperidone Palmitate; Polyglactin 910; Prolactin; Pyrimidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Young Adult	2013
The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: a preliminary open-label trial. International journal of psychiatry in clinical practice, 2014, Volume: 18, Issue:1 Topics: Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Cognition Disorders; Drug Substitution; Dyskinesia, Drug-Induced; Female; Humans; Isoxazoles; Male; Memory, Short-Term; Neuropsychological Tests; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome	2014
Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison. International clinical psychopharmacology, 2014, Volume: 29, Issue:1 Topics: Adult; Age of Onset; Antipsychotic Agents; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Isoxazoles; Male; Muscle Rigidity; Paliperidone Palmitate; Palmitates; Prolactin; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome	2014
Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study. Current medical research and opinion, 2014, Volume: 30, Issue:4 Topics: Administration, Oral; Adult; Delayed-Action Preparations; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Patient Satisfaction; Prospective Studies; Pyrimidines; Quality of Life; Risperidone; Schizophrenia; Severity of Illness Index	2014
Changes in plasma concentrations of risperidone and 9-hydroxyrisperidone and the associated clinical effects during the switch from oral risperidone to extended-release paliperidone tablets in patients with schizophrenia. Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:4 Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Time Factors; Young Adult	2014
Population pharmacokinetics and prediction of dopamine D2 receptor occupancy after multiple doses of RBP-7000, a new sustained-release formulation of risperidone, in schizophrenia patients on stable oral risperidone treatment. Clinical pharmacokinetics, 2014, Volume: 53, Issue:6 Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Injections, Subcutaneous; Isoxazoles; Male; Middle Aged; Models, Biological; Paliperidone Palmitate; Pyrimidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Young Adult	2014
A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia. Schizophrenia research, 2014, Volume: 154, Issue:1-3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Young Adult	2014
Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:7 Topics: Antipsychotic Agents; Double-Blind Method; Humans; Injections; Isoxazoles; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia	2014
Population pharmacokinetic modeling and simulation to guide dose selection for RBP-7000, a new sustained-release formulation of risperidone. Journal of clinical pharmacology, 2015, Volume: 55, Issue:1 Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Humans; Isoxazoles; Male; Middle Aged; Models, Biological; Paliperidone Palmitate; Palmitates; Pyrimidines; Risperidone	2015
Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics. Progress in neuro-psychopharmacology & biological psychiatry, 2015, Apr-03, Volume: 58 Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Female; Humans; Male; Paliperidone Palmitate; Prospective Studies; Psychiatric Status Rating Scales; Retreatment; Risperidone; Schizophrenia; Time Factors; Treatment Outcome	2015
Paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with risperidone long-acting therapy or frequently used conventional depot antipsychotics. Journal of psychopharmacology (Oxford, England), 2015, Volume: 29, Issue:8 Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Paliperidone Palmitate; Prospective Studies; Risperidone; Schizophrenia; Severity of Illness Index	2015
The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial. Neuropsychobiology, 2016, Volume: 73, Issue:1 Topics: Adult; Antipsychotic Agents; Female; Humans; Japan; Male; Middle Aged; Neuropsychological Tests; Paliperidone Palmitate; Pilot Projects; Risperidone; Schizophrenia; Social Behavior; Treatment Outcome	2016
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial. BMC psychiatry, 2016, 05-29, Volume: 16 Topics: Adult; Antipsychotic Agents; Cognition; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome	2016
Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole. Clinical pharmacology in drug development, 2016, Volume: 5, Issue:6 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Specimen Collection; Capillaries; Female; Fingers; Half-Life; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Risperidone; Veins; Young Adult	2016
Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia. CNS spectrums, 2016, Volume: 21, Issue:6 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Delayed-Action Preparations; Female; Haloperidol; Humans; Hyperprolactinemia; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Perphenazine; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Failure; Treatment Outcome	2016
Exposure-response analysis after subcutaneous administration of RBP-7000, a once-a-month long-acting Atrigel formulation of risperidone. British journal of clinical pharmacology, 2017, Volume: 83, Issue:7 Topics: Absorbable Implants; Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Drug Implants; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Paliperidone Palmitate; Placebos; Polyglactin 910; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome	2017
Cost-effectiveness of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA. Journal of comparative effectiveness research, 2018, Volume: 7, Issue:7 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Administration Schedule; Drug Costs; Female; Humans; Injections, Intramuscular; Male; Markov Chains; Middle Aged; Paliperidone Palmitate; Piperazines; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Young Adult	2018
Paliperidone Palmitate 3-Monthly Versus 1-Monthly Injectable in Patients With Schizophrenia With or Without Prior Exposure to Oral Risperidone or Paliperidone: A Post Hoc, Subgroup Analysis. Clinical drug investigation, 2018, Volume: 38, Issue:8 Topics: Administration, Oral; Adult; Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Injections, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Recurrence; Risperidone; Schizophrenia; Treatment Outcome; Weight Gain	2018
Effects of Risperidone and Paliperidone on Brain-Derived Neurotrophic Factor and N400 in First-Episode Schizophrenia. Chinese medical journal, 2018, Oct-05, Volume: 131, Issue:19 Topics: Antipsychotic Agents; Brain-Derived Neurotrophic Factor; China; Electroencephalography; Evoked Potentials; Female; Humans; Male; Paliperidone Palmitate; Risperidone; Schizophrenia	2018
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics. BMC psychiatry, 2018, 12-04, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Predictive Value of Tests; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Young Adult	2018
Initial severity of the Positive and Negative Syndrome Scale (PANSS)-30, its main subscales plus the PANSS-6, and the relationship to subsequent improvement and trial dropout: a pooled participant-level analysis of 18 placebo-controlled risperidone and pa Translational psychiatry, 2023, 06-07, Volume: 13, Issue:1 Topics: Antipsychotic Agents; Double-Blind Method; Humans; Paliperidone Palmitate; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome	2023
Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial. Translational psychiatry, 2023, Jun-10, Volume: 13, Issue:1 Topics: Antipsychotic Agents; Australia; Cognition; Female; Humans; Paliperidone Palmitate; Psychotic Disorders; Risperidone	2023

Other Studies

264 other study(ies) available for risperidone and paliperidone palmitate

Article	Year
Determination of risperidone and 9-hydroxyrisperidone in plasma, urine and animal tissues by high-performance liquid chromatography. Journal of chromatography, 1992, Dec-02, Volume: 583, Issue:2 Topics: Animals; Calibration; Chromatography, High Pressure Liquid; Isoxazoles; Paliperidone Palmitate; Piperidines; Pyrimidines; Quality Control; Reproducibility of Results; Risperidone; Spectrophotometry, Ultraviolet	1992
The pharmacokinetics of risperidone in humans: a summary. The Journal of clinical psychiatry, 1994, Volume: 55 Suppl Topics: Aged; Animals; Antipsychotic Agents; Biotransformation; Dogs; Half-Life; Humans; Isoxazoles; Liver Cirrhosis; Male; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Reference Values; Renal Insufficiency; Risperidone; Schizophrenia	1994
Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. The Journal of clinical psychiatry, 1994, Volume: 55 Suppl Topics: Animals; Antipsychotic Agents; Brain; Clone Cells; Clozapine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Guinea Pigs; Haloperidol; Humans; Isoxazoles; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Serotonin Antagonists	1994
Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat. Psychopharmacology, 1994, Volume: 114, Issue:1 Topics: Animals; Antiemetics; Antipsychotic Agents; Apomorphine; Brain; Dogs; Half-Life; Injections, Subcutaneous; Isoxazoles; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Organ Size; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Rats, Wistar; Receptors, Neurotransmitter; Risperidone; Spectrophotometry, Ultraviolet; Tryptamines	1994
Plasma protein binding of risperidone and its distribution in blood. Psychopharmacology, 1994, Volume: 114, Issue:4 Topics: Adult; Aged; Animals; Antipsychotic Agents; Blood Cells; Blood Proteins; Dogs; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Isoxazoles; Kidney Diseases; Liver Diseases; Male; Middle Aged; Orosomucoid; Paliperidone Palmitate; Piperidines; Protein Binding; Pyrimidines; Rats; Rats, Wistar; Risperidone; Serum Albumin	1994
Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection. Journal of chromatography, 1993, May-05, Volume: 614, Issue:2 Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Isoxazoles; Paliperidone Palmitate; Piperidines; Pyrimidines; Regression Analysis; Risperidone	1993
Therapeutic drug monitoring of risperidone and 9-hydroxyrisperidone in serum with solid-phase extraction and high-performance liquid chromatography. Therapeutic drug monitoring, 1997, Volume: 19, Issue:3 Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone	1997
Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in serum from patients comedicated with other psychotropic drugs. Journal of chromatography. B, Biomedical sciences and applications, 1997, Sep-26, Volume: 698, Issue:1-2 Topics: Antipsychotic Agents; Artifacts; Chromatography, High Pressure Liquid; Haloperidol; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Spectrophotometry, Ultraviolet	1997
Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat. Psychopharmacology, 1998, Volume: 139, Issue:4 Topics: Animals; Antipsychotic Agents; Brain; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Tissue Distribution	1998
Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4. Naunyn-Schmiedeberg's archives of pharmacology, 1999, Volume: 359, Issue:2 Topics: Animals; Antipsychotic Agents; Biotransformation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA, Complementary; Humans; Isoenzymes; Isoxazoles; Microsomes, Liver; Mixed Function Oxygenases; Paliperidone Palmitate; Pyrimidines; Rats; Recombinant Proteins; Risperidone	1999
Effect of venlafaxine on the pharmacokinetics of risperidone. Journal of clinical pharmacology, 1999, Volume: 39, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Area Under Curve; Cyclohexanols; Desvenlafaxine Succinate; Exploratory Behavior; Female; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Middle Aged; Paliperidone Palmitate; Psychomotor Performance; Pyrimidines; Risperidone; Venlafaxine Hydrochloride	1999
Pharmacokinetic-pharmacodynamic modeling of risperidone effects on electroencephalography in healthy volunteers. Psychopharmacology, 1999, Volume: 144, Issue:3 Topics: Administration, Oral; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Electroencephalography; Humans; Isoxazoles; Male; Models, Biological; Paliperidone Palmitate; Pyrimidines; Risperidone	1999
A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:7 Topics: Adolescent; Adult; Antipsychotic Agents; Aryl Hydrocarbon Hydroxylases; Case-Control Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Oxidoreductases, N-Demethylating; Paliperidone Palmitate; Pilot Projects; Pyrimidines; Risperidone	1999
Simultaneous determination of paroxetine, risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with coulometric detection. Pharmacology, 2000, Volume: 60, Issue:1 Topics: Chromatography, High Pressure Liquid; Colorimetry; Drug Monitoring; Humans; Isoxazoles; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Spectrophotometry, Ultraviolet	2000
Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2 Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Breast Feeding; Female; Humans; Infant, Newborn; Isoxazoles; Milk, Human; Paliperidone Palmitate; Pregnancy; Pyrimidines; Risperidone	2000
Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions. British journal of clinical pharmacology, 2000, Volume: 49 Suppl 1 Topics: Antipsychotic Agents; Biotransformation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Isoxazoles; Liver; Microsomes, Liver; Paliperidone Palmitate; Piperazines; Pyrimidines; Risperidone; Sulfones; Sulfoxides; Thiazoles	2000
Simultaneous determination of risperidone and 9-hydroxyrisperidone in plasma by liquid chromatography/electrospray tandem mass spectrometry. Journal of mass spectrometry : JMS, 2000, Volume: 35, Issue:6 Topics: Animals; Antipsychotic Agents; Chromatography, Liquid; Humans; Isoxazoles; Mass Spectrometry; Paliperidone Palmitate; Pyrimidines; Rats; Risperidone; Schizophrenia; Sensitivity and Specificity	2000
Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate. Therapeutic drug monitoring, 2000, Volume: 22, Issue:4 Topics: Adult; Antipsychotic Agents; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Mixed Function Oxygenases; Paliperidone Palmitate; Pyrimidines; Risperidone; Valproic Acid	2000
Risperidone metabolism and the impact of being a cytochrome P450 2D6 ultrarapid metabolizer. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:8 Topics: Adolescent; Adult; Cytochrome P-450 CYP2D6; Drug Monitoring; Genotype; Humans; Isoxazoles; Male; Paliperidone Palmitate; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimidines; Risperidone	2000
Determination of risperidone and its major metabolite 9-hydroxyrisperidone in human plasma by reversed-phase liquid chromatography with ultraviolet detection. Journal of chromatography. B, Biomedical sciences and applications, 2000, Sep-15, Volume: 746, Issue:2 Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Sensitivity and Specificity; Spectrophotometry, Ultraviolet	2000
Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine. Therapeutic drug monitoring, 2001, Volume: 23, Issue:3 Topics: Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Selective Serotonin Reuptake Inhibitors	2001
Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms. Preliminary study. Neuropsychobiology, 2001, Volume: 44, Issue:3 Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia	2001
Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats. Psychopharmacology, 2002, Volume: 159, Issue:4 Topics: Administration, Oral; Animals; Antipsychotic Agents; Brain; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin Antagonists; Tissue Distribution	2002
In vivo and in vitro myocardial binding of risperidone and 9-hydroxyrisperidone. Toxicology and applied pharmacology, 2002, Apr-15, Volume: 180, Issue:2 Topics: Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Guinea Pigs; Isoxazoles; Myocardium; Paliperidone Palmitate; Pyrimidines; Risperidone	2002
Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in plasma after overdose. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2002, Jun-05, Volume: 772, Issue:2 Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Overdose; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Sensitivity and Specificity	2002
Risperidone and 9-hydroxyrisperidone concentrations are not dependent on age or creatinine clearance among elderly subjects. Journal of geriatric psychiatry and neurology, 2002,Summer, Volume: 15, Issue:2 Topics: Age Factors; Aged; Aged, 80 and over; Aging; Antipsychotic Agents; Creatinine; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Radioimmunoassay; Risperidone	2002
Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy. Synapse (New York, N.Y.), 2002, Volume: 46, Issue:1 Topics: Antipsychotic Agents; Basal Ganglia Diseases; Dopamine Antagonists; Humans; Isoxazoles; Models, Biological; Paliperidone Palmitate; Pyrimidines; Receptors, Dopamine D2; Risperidone	2002
A colloidal graphite-coated emitter for sheathless capillary electrophoresis/nanoelectrospray ionization mass spectrometry. Analytical chemistry, 2002, Oct-15, Volume: 74, Issue:20 Topics: Colloids; Electrophoresis, Capillary; Graphite; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Spectrometry, Mass, Electrospray Ionization	2002
Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003, Jan-05, Volume: 783, Issue:1 Topics: Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Drug Interactions; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone	2003
Validated method for the determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography-tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003, Jan-15, Volume: 783, Issue:2 Topics: Antipsychotic Agents; Chromatography, Liquid; Humans; Isoxazoles; Mass Spectrometry; Paliperidone Palmitate; Pyrimidines; Risperidone	2003
Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients. Pharmacopsychiatry, 2002, Volume: 35, Issue:6 Topics: Adult; Aged; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Genotype; Humans; Isoxazoles; Middle Aged; Paliperidone Palmitate; Phenotype; Pyrimidines; Risperidone; Schizophrenia; White People	2002
[Determination of risperidone and 9-hydroxyrisperidone in plasma by high performance liquid chromatography]. Se pu = Chinese journal of chromatography, 1999, Volume: 17, Issue:4 Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Serotonin Antagonists	1999
Effects of CYP2D6 genotypes on plasma concentrations of risperidone and enantiomers of 9-hydroxyrisperidone in Japanese patients with schizophrenia. Journal of clinical pharmacology, 2003, Volume: 43, Issue:2 Topics: Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Genotype; Half-Life; Humans; Hydroxylation; Isoxazoles; Japan; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Stereoisomerism	2003
Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia. Therapeutic drug monitoring, 2003, Volume: 25, Issue:3 Topics: Adult; Analysis of Variance; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Isoxazoles; Japan; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia	2003
Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidone. Therapeutic drug monitoring, 2003, Volume: 25, Issue:6 Topics: Adult; Antipsychotic Agents; Drug Monitoring; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone	2003
Transfer of risperidone and 9-hydroxyrisperidone into human milk. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:2 Topics: Adult; Area Under Curve; Breast Feeding; Depression, Postpartum; Female; Galactorrhea; Humans; Infant; Isoxazoles; Male; Milk, Human; Paliperidone Palmitate; Pyrimidines; Risperidone	2004
Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry. Journal of chromatography. A, 2004, Feb-13, Volume: 1026, Issue:1-2 Topics: Adult; Calibration; Chemical Precipitation; Child; Chromatography, Liquid; Humans; Isoxazoles; Mass Spectrometry; Molecular Structure; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Saliva; Sensitivity and Specificity	2004
Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes. British journal of clinical pharmacology, 2004, Volume: 57, Issue:5 Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Genes, MDR; Genotype; Humans; Isoxazoles; Male; Middle Aged; Mutation; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Risperidone; Schizophrenia	2004
QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations. Journal of psychopharmacology (Oxford, England), 2004, Volume: 18, Issue:2 Topics: Administration, Oral; Adult; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Electrocardiography; Genotype; Humans; Isoxazoles; Long QT Syndrome; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone	2004
In vitro effects of risperidone and 9-hydroxy-risperidone on human platelet function, plasma coagulation, and fibrinolysis. Clinical therapeutics, 2004, Volume: 26, Issue:8 Topics: Adult; Animals; Aorta; Arachidonic Acid; Blood Coagulation Tests; Clonidine; Epinephrine; Ergotamine; Fibrinolysis; Humans; Isoxazoles; Male; Milrinone; Paliperidone Palmitate; Platelet Aggregation; Pyrimidines; Rats; Rats, Wistar; Reference Values; Risperidone; Serotonin; Serotonin Antagonists; Suprofen	2004
A high-performance liquid chromatographic-atmospheric pressure chemical ionization-tandem mass spectrometric method for determination of risperidone and 9-hydroxyrisperidone in human plasma. Journal of analytical toxicology, 2004, Volume: 28, Issue:6 Topics: Antipsychotic Agents; Calibration; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Indicators and Reagents; Isoxazoles; Mass Spectrometry; Paliperidone Palmitate; Pyrimidines; Quality Control; Reference Standards; Reproducibility of Results; Risperidone	2004
The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein. The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:4 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Chromatography, High Pressure Liquid; Injections, Intraperitoneal; Isoxazoles; Male; Mice; Mice, Transgenic; Paliperidone Palmitate; Pyrimidines; Risperidone; Serotonin Antagonists; Tissue Distribution	2004
Risperidone and breast-feeding. Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:2 Topics: Adult; Antipsychotic Agents; Breast Feeding; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Isoxazoles; Milk, Human; Paliperidone Palmitate; Postpartum Period; Psychotic Disorders; Pyrimidines; Risperidone	2005
Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6. International clinical psychopharmacology, 2005, Volume: 20, Issue:2 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Caffeine; Catecholamines; Central Nervous System Stimulants; Cotinine; Cues; Cytochrome P-450 CYP2D6; Female; Homovanillic Acid; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Smoking	2005
Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels. The American journal of psychiatry, 2005, Volume: 162, Issue:5 Topics: Adolescent; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyperprolactinemia; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Psychotic Disorders; Pyrimidines; Risperidone	2005
Influence of age and gender on risperidone plasma concentrations. Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Antipsychotic Agents; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Sex Characteristics	2005
Subtherapeutic risperidone serum concentrations in an adolescent during hemodialysis: a pharmacological puzzle. Therapeutic drug monitoring, 2005, Volume: 27, Issue:5 Topics: Adolescent; Antipsychotic Agents; Drug Monitoring; Female; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Renal Dialysis; Risperidone; Tics	2005
Plasma risperidone levels and clinical response in patients with first-episode psychosis. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6 Topics: Adult; Antipsychotic Agents; Asian People; Drug Monitoring; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Treatment Outcome	2005
Intestinal uptake and biodistribution of novel polymeric micelles after oral administration. Journal of controlled release : official journal of the Controlled Release Society, 2006, Mar-10, Volume: 111, Issue:1-2 Topics: Administration, Oral; Animals; Antipsychotic Agents; Area Under Curve; Biological Availability; Biological Transport; Caco-2 Cells; Carbon Radioisotopes; Enterocytes; Humans; Injections, Intravenous; Intestinal Absorption; Isoxazoles; Kidney; Male; Metabolic Clearance Rate; Micelles; Mononuclear Phagocyte System; Paliperidone Palmitate; Polyesters; Polyethylene Glycols; Polymers; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Tissue Distribution	2006
Multiple dose pharmacokinetics of risperidone and 9-hydroxyrisperidone in Chinese female patients with schizophrenia. Acta pharmacologica Sinica, 2006, Volume: 27, Issue:3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Area Under Curve; Asian People; China; Female; Humans; Isoxazoles; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia	2006
A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone. The American journal of psychiatry, 2006, Volume: 163, Issue:3 Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Carbon Radioisotopes; Corpus Striatum; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Positron-Emission Tomography; Prolactin; Psychotic Disorders; Pyrimidines; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia	2006
Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication. Acta psychiatrica Scandinavica, 2006, Volume: 114, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome	2006
Liquid chromatography/tandem mass spectrometry method for simultaneous determination of risperidone and its active metabolite 9-hydroxyrisperidone in human plasma. Rapid communications in mass spectrometry : RCM, 2006, Volume: 20, Issue:14 Topics: Administration, Oral; Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Isoxazoles; Male; Microchemistry; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry	2006
Positive modulation of glutamatergic receptors potentiates the suppressive effects of antipsychotics on conditioned avoidance responding in rats. Pharmacology, biochemistry, and behavior, 2006, Volume: 84, Issue:2 Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Clozapine; Conditioning, Psychological; Dioxoles; Drug Synergism; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Rats, Wistar; Receptors, AMPA; Risperidone; Serine; Stereoisomerism	2006
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein. Psychopharmacology, 2006, Volume: 187, Issue:4 Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodiazepines; Chlorpromazine; Clozapine; Cyclosporins; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Flow Cytometry; Fluorescent Dyes; Haloperidol; Isoxazoles; Kidney; Liver; LLC-PK1 Cells; Olanzapine; Paliperidone Palmitate; Pyrimidines; Quetiapine Fumarate; Rhodamine 123; Risperidone; Swine; Transfection	2006
Risperidone and paliperidone inhibit p-glycoprotein activity in vitro. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:4 Topics: Animals; Animals, Newborn; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cerebral Cortex; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Epithelial Cells; Inhibitory Concentration 50; Isoxazoles; Paliperidone Palmitate; Protein Transport; Pyrimidines; Rats; Rhodamine 123; Risperidone; Swine; Time Factors	2007
Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients. Pharmacogenomics, 2006, Volume: 7, Issue:7 Topics: Adult; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; China; Female; Gene Frequency; Humans; Isoxazoles; Linkage Disequilibrium; Male; Organic Anion Transporters; Paliperidone Palmitate; Polymorphism, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology	2006
Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite. Human psychopharmacology, 2006, Volume: 21, Issue:8 Topics: Adult; Antipsychotic Agents; Biotransformation; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia	2006
Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients. Pharmacopsychiatry, 2007, Volume: 40, Issue:1 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Drug Interactions; Female; Homovanillic Acid; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychomotor Agitation; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Valproic Acid	2007
Determination of risperidone and enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MS. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Jun-01, Volume: 852, Issue:1-2 Topics: Child; Chromatography, Liquid; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Reference Standards; Reproducibility of Results; Risperidone; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Tandem Mass Spectrometry	2007
Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Jun-30, Volume: 31, Issue:5 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Catecholamines; Chromatography, High Pressure Liquid; Female; Genotype; Humans; Immunoenzyme Techniques; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Risperidone; Schizophrenia	2007
Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons. Psychopharmacology, 2007, Volume: 194, Issue:1 Topics: Adrenergic Uptake Inhibitors; Animals; Antipsychotic Agents; Citalopram; Desipramine; Dose-Response Relationship, Drug; Electrophysiology; Infusion Pumps; Injections, Intravenous; Isoxazoles; Male; Neurons; Norepinephrine; Paliperidone Palmitate; Piperazines; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists	2007
Limitations in discerning the effects of risperidone and its 9-hydroxy metabolite on prolactin levels in a small study of patients with schizophrenia. Human psychopharmacology, 2007, Volume: 22, Issue:5 Topics: Antipsychotic Agents; Humans; Isoxazoles; Paliperidone Palmitate; Prolactin; Pyrimidines; Risperidone; Schizophrenia	2007
Enantioselective analysis of the antipsychotic 9-hydroxyrisperidone, main metabolite of risperidone, by chiral capillary EKC using dual CDs. Electrophoresis, 2007, Volume: 28, Issue:15 Topics: beta-Cyclodextrins; Chromatography, Micellar Electrokinetic Capillary; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Stereoisomerism	2007
Analytical and semipreparative enantioseparation of 9-hydroxyrisperidone, the main metabolite of risperidone, using high-performance liquid chromatography and capillary electrophoresis. Validation and determination of enantiomeric purity. Journal of chromatography. A, 2007, Sep-07, Volume: 1163, Issue:1-2 Topics: Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Isoxazoles; Molecular Structure; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Stereoisomerism	2007
[Development and identifiability analysis of parent-metabolite pharmacokinetic model for risperidone and its main active metabolite 9-hydroxyrisperidone]. Yao xue xue bao = Acta pharmaceutica Sinica, 2007, Volume: 42, Issue:6 Topics: Adult; Cytochrome P-450 CYP2D6; Humans; Isoxazoles; Male; Models, Biological; Monte Carlo Method; Paliperidone Palmitate; Pyrimidines; Risperidone	2007
Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia. Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:8 Topics: Adolescent; Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Prolactin; Pyrimidines; Risperidone; Schizophrenia	2007
Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Oct-15, Volume: 858, Issue:1-2 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Chromatography, Liquid; Clozapine; Haloperidol; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Rats; Reproducibility of Results; Risperidone; Tandem Mass Spectrometry; Thiazoles	2007
Relationship between prolactin secretion, and plasma risperidone and 9-hydroxyrisperidone concentrations in adolescents with schizophreniform disorder. Psychoneuroendocrinology, 2008, Volume: 33, Issue:2 Topics: Adolescent; Adolescent Medicine; Age Factors; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Isoxazoles; Male; Paliperidone Palmitate; Prolactin; Psychotic Disorders; Pyrimidines; Risperidone	2008
Pharmacodynamic consequences of P-glycoprotein-dependent pharmacokinetics of risperidone and haloperidol in mice. Behavioural brain research, 2008, Apr-09, Volume: 188, Issue:2 Topics: Animals; Antipsychotic Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Behavior, Animal; Brain; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Haloperidol; Isoxazoles; Male; Mice; Mice, Knockout; Motor Activity; Paliperidone Palmitate; Pyrimidines; Risperidone; Time Factors	2008
Paliperidone: An improvement over risperidone? American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Mar-01, Volume: 65, Issue:5 Topics: Administration, Oral; Antipsychotic Agents; Delayed-Action Preparations; Humans; Isoxazoles; Marketing; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia	2008
Validated LC-MS/MS methods for the determination of risperidone and the enantiomers of 9-hydroxyrisperidone in human plasma and urine. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008, Jul-01, Volume: 870, Issue:1 Topics: Chromatography, Liquid; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Sensitivity and Specificity; Tandem Mass Spectrometry	2008
Long-term therapeutic drug monitoring of risperidone and olanzapine identifies altered steady-state pharmacokinetics: a clinical, two-group, naturalistic study. Clinical drug investigation, 2008, Volume: 28, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antipsychotic Agents; Benzodiazepines; Biotransformation; Cytochrome P-450 CYP2D6; Drug Monitoring; Female; Humans; Inpatients; Isoxazoles; Male; Mental Disorders; Middle Aged; Olanzapine; Paliperidone Palmitate; Pyrimidines; Regression Analysis; Risperidone; Schizophrenia; Young Adult	2008
ABCB1 polymorphisms influence steady-state plasma levels of 9-hydroxyrisperidone and risperidone active moiety. Therapeutic drug monitoring, 2008, Volume: 30, Issue:5 Topics: Adult; Alleles; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Genetic Variation; Genotype; Haplotypes; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Risperidone	2008
Impact of multiple inhibitors or substrates of cytochrome P450 2D6 on plasma risperidone levels in patients on polypharmacy. Therapeutic drug monitoring, 2008, Volume: 30, Issue:5 Topics: Adult; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Polypharmacy; Pyrimidines; Risperidone; Substrate Specificity	2008
Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:3 Topics: Adenosine Triphosphate; Antipsychotic Agents; Cell Line; Cell Survival; Dibenzothiazepines; Dose-Response Relationship, Drug; Energy Metabolism; Humans; Isoxazoles; Monocytes; Neurons; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Risperidone; Thiazoles	2010
[Paliperidone--a novel second-generation antipsychotic]. Ugeskrift for laeger, 2008, Aug-25, Volume: 170, Issue:35 Topics: Antipsychotic Agents; Delayed-Action Preparations; Evidence-Based Medicine; Half-Life; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Treatment Outcome	2008
Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study. British journal of clinical pharmacology, 2008, Volume: 66, Issue:5 Topics: Adult; Age Factors; Aged; Alzheimer Disease; Antipsychotic Agents; Biological Availability; Body Weight; Female; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Middle Aged; Models, Chemical; Models, Statistical; Paliperidone Palmitate; Pyrimidines; Randomized Controlled Trials as Topic; Risperidone; Sample Size; Sampling Studies; Schizophrenia	2008
Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists. Molecular pharmacology, 2009, Volume: 75, Issue:2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cell Line; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Receptors, Serotonin; Risperidone; Serotonin Antagonists	2009
Study of the complexation of risperidone and 9-hydroxyrisperidone with cyclodextrin hosts using affinity capillary electrophoresis and (1)H NMR spectroscopy. Journal of chromatography. A, 2008, Dec-26, Volume: 1215, Issue:1-2 Topics: Antipsychotic Agents; Cyclodextrins; Electrophoresis, Capillary; Isoxazoles; Magnetic Resonance Spectroscopy; Molecular Structure; Paliperidone Palmitate; Pyrimidines; Risperidone; Thermodynamics	2008
An agonist-antagonist interaction model for prolactin release following risperidone and paliperidone treatment. Clinical pharmacology and therapeutics, 2009, Volume: 85, Issue:4 Topics: Drug Interactions; Female; Humans; Isoxazoles; Male; Models, Biological; Paliperidone Palmitate; Prolactin; Pyrimidines; Risperidone	2009
Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2009, Volume: 17, Issue:3 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Basal Ganglia Diseases; Case-Control Studies; Cross-Sectional Studies; Dopamine Antagonists; Female; Humans; Isoxazoles; Male; Middle Aged; Ontario; Paliperidone Palmitate; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia; Treatment Outcome	2009
Determination of risperidone and 9-Hydroxyrisperidone using HPLC, in plasma of children and adolescents with emotional and behavioural disorders. Biomedical chromatography : BMC, 2009, Volume: 23, Issue:9 Topics: Adolescent; Antipsychotic Agents; Child; Chromatography, High Pressure Liquid; Female; Humans; Isoxazoles; Linear Models; Male; Mental Disorders; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Sensitivity and Specificity	2009
Effects of the CYP2D610 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia. Human psychopharmacology, 2009, Volume: 24, Issue:4* Topics: Adult; Alleles; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Drug Therapy, Combination; Female; Genotype; Humans; Isoxazoles; Male; Oligonucleotide Array Sequence Analysis; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Regression Analysis; Risperidone; Schizophrenia	2009
Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:7 Topics: Adolescent; Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; DNA; Dose-Response Relationship, Drug; Female; Genotype; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult	2010
Effects of CYP2D6 and CYP3A5 genotypes on the plasma concentrations of risperidone and 9-hydroxyrisperidone in Korean schizophrenic patients. Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:3 Topics: Adult; Antipsychotic Agents; Asian People; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Genotype; Humans; Isoxazoles; Korea; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Risperidone; Schizophrenia	2009
Pharmacokinetics and efficacy of a direct switch from conventional depot to risperidone long-acting injection in Chinese patients with schizophrenic and schizoaffective disorders. Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Asian People; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome; White People	2009
Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:7 Topics: Adult; Aged; Antipsychotic Agents; Anxiety; Cognition; Data Interpretation, Statistical; Depression; Female; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult	2010
Human 5-HT7 receptor-induced inactivation of forskolin-stimulated adenylate cyclase by risperidone, 9-OH-risperidone and other "inactivating antagonists". Molecular pharmacology, 2009, Volume: 76, Issue:3 Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Cell Line; Colforsin; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Receptors, Serotonin; Risperidone; Serotonin Antagonists	2009
Serum levels of risperidone and its metabolite, 9-hydroxyrisperidone: correlation between drug concentration and clinical response. Therapeutic drug monitoring, 2009, Volume: 31, Issue:4 Topics: Adult; Antipsychotic Agents; Attention; Blood Chemical Analysis; Discrimination Learning; Drug Monitoring; Female; Humans; Hydroxylation; Isoxazoles; Liver; Male; Neuropsychological Tests; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenic Psychology	2009
Simultaneous determination of risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by liquid chromatography with electrochemical detection. Journal of pharmaceutical and biomedical analysis, 2009, Dec-05, Volume: 50, Issue:5 Topics: Antipsychotic Agents; Buffers; Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Chromatography, Liquid; Electrochemistry; Humans; Isoxazoles; Methanol; Paliperidone Palmitate; Phosphates; Pyrimidines; Reproducibility of Results; Risperidone; Stereoisomerism; Time Factors	2009
Time resolved analysis of risperidone and 9-hydroxy-risperidone in hair using LC/MS-MS. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009, Aug-15, Volume: 877, Issue:24 Topics: Adult; Antipsychotic Agents; Chromatography, Liquid; Hair; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Tandem Mass Spectrometry; Time Factors	2009
A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats. European psychiatry : the journal of the Association of European Psychiatrists, 2010, Volume: 25, Issue:2 Topics: Animals; Antipsychotic Agents; Dextroamphetamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Administration Schedule; Infusions, Subcutaneous; Injections, Subcutaneous; Isoxazoles; Locomotion; Male; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone	2010
Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission? The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Oct-28, Volume: 29, Issue:43 Topics: Adult; Antipsychotic Agents; Brain; Carbon Radioisotopes; Caudate Nucleus; Dopamine; Dose-Response Relationship, Drug; Humans; Isoxazoles; Levodopa; Male; Paliperidone Palmitate; Positron-Emission Tomography; Putamen; Pyrimidines; Raclopride; Receptors, Dopamine D2; Rest; Risperidone; Synaptic Transmission; Young Adult	2009
Impact of CYP2D6 genotype on steady-state serum concentrations of risperidone and 9-hydroxyrisperidone in patients using long-acting injectable risperidone. Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Female; Genotype; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Retrospective Studies; Risperidone; Time Factors; Young Adult	2009
Inconsistency in risperidone long-acting injection steady-state plasma levels when switching from deltoid to gluteal administration. Journal of clinical pharmacology, 2010, Volume: 50, Issue:6 Topics: Adult; Antipsychotic Agents; Buttocks; Delayed-Action Preparations; Humans; Injections, Intramuscular; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Shoulder	2010
Remission of drug-induced hepatitis after switching from risperidone to paliperidone. The American journal of psychiatry, 2010, Volume: 167, Issue:3 Topics: Adult; Antipsychotic Agents; Biotransformation; Chemical and Drug Induced Liver Injury; Clozapine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Isoxazoles; Liver Function Tests; Paliperidone Palmitate; Pyrimidines; Reference Values; Risperidone; Schizophrenia	2010
Serum concentrations, therapeutic response and side effects in children and adolescents with impulsive-aggressive symptoms during risperidone therapy. Pharmacopsychiatry, 2010, Volume: 43, Issue:2 Topics: Adolescent; Age Factors; Aggression; Antipsychotic Agents; Child; Child Behavior Disorders; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Linear Models; Male; Paliperidone Palmitate; Prospective Studies; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Sex Factors; Treatment Outcome	2010
Serum concentrations of paliperidone versus risperidone and clinical effects. European journal of clinical pharmacology, 2010, Volume: 66, Issue:8 Topics: Adult; Antipsychotic Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Monitoring; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Retrospective Studies; Risperidone	2010
The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone. European journal of clinical pharmacology, 2010, Volume: 66, Issue:11 Topics: Adult; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Isoxazoles; Male; Middle Aged; Mutation; Paliperidone Palmitate; Pyrimidines; Risperidone; Sample Size; Schizophrenia; Treatment Outcome	2010
Studies on the acute toxicity, pharmacokinetics and pharmacodynamics of paliperidone derivatives--comparison to paliperidone and risperidone in mice and rats. Basic & clinical pharmacology & toxicology, 2010, Volume: 107, Issue:2 Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Electrocardiography; Excitatory Amino Acid Antagonists; Female; Heart; Heart Rate; Hyperkinesis; Isoxazoles; Lethal Dose 50; Male; Maximum Tolerated Dose; Mice; Mice, Inbred Strains; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Toxicity Tests, Acute	2010
Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats. Brain research, 2010, Oct-01, Volume: 1354 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Cell Count; Cell Proliferation; Dose-Response Relationship, Drug; Fluoxetine; Hippocampus; Isoxazoles; Lateral Ventricles; Male; Neurogenesis; Neurons; Olfactory Mucosa; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Selective Serotonin Reuptake Inhibitors	2010
Clozapine and other competitive antagonists reactivate risperidone-inactivated h5-HT7 receptors: radioligand binding and functional evidence for GPCR homodimer protomer interactions. Psychopharmacology, 2010, Volume: 212, Issue:4 Topics: Binding, Competitive; Biosensing Techniques; Cell Line; Clozapine; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Isoxazoles; Paliperidone Palmitate; Protein Binding; Protein Multimerization; Protein Subunits; Pyrimidines; Radioligand Assay; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Transfection	2010
Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases. Current drug safety, 2011, Feb-01, Volume: 6, Issue:1 Topics: Chemistry, Pharmaceutical; Clinical Trials as Topic; Conscious Sedation; Databases, Factual; Delayed-Action Preparations; Delirium; Humans; Injections, Intramuscular; Isoxazoles; Paliperidone Palmitate; Palmitates; Prospective Studies; Risperidone; Syndrome	2011
Effect of cyamemazine on the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: a preliminary retrospective study. Therapeutic drug monitoring, 2010, Volume: 32, Issue:6 Topics: Adolescent; Adult; Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Interactions; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Phenothiazines; Pyrimidines; Retrospective Studies; Risperidone; Spectrophotometry, Ultraviolet	2010
Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Jan-15, Volume: 879, Issue:2 Topics: Chromatography, Liquid; Humans; Isoxazoles; Linear Models; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Reproducibility of Results; Risperidone; Saliva; Sensitivity and Specificity; Solid Phase Microextraction; Spectrophotometry, Ultraviolet	2011
Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis. BMC psychiatry, 2011, Feb-07, Volume: 11 Topics: Administration, Oral; Adult; Antipsychotic Agents; Databases as Topic; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Propensity Score; Psychiatric Status Rating Scales; Pyrimidines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Treatment Outcome	2011
The interaction of antipsychotic drugs with lipids and subsequent lipid reorganization investigated using biophysical methods. Biochimica et biophysica acta, 2011, Volume: 1808, Issue:8 Topics: 1,2-Dipalmitoylphosphatidylcholine; Antipsychotic Agents; Calorimetry, Differential Scanning; Cell Membrane; Cholesterol; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Isoxazoles; Membrane Lipids; Membranes, Artificial; Microscopy, Fluorescence; Models, Molecular; Molecular Conformation; Molecular Structure; Paliperidone Palmitate; Phosphatidylcholines; Pyrimidines; Receptors, Dopamine D2; Risperidone; Sphingomyelins; Structure-Activity Relationship; Surface Plasmon Resonance; X-Ray Diffraction	2011
Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation. Journal of psychiatric research, 2011, Volume: 45, Issue:9 Topics: Amphetamine; Animals; Animals, Newborn; Antipsychotic Agents; Central Nervous System Stimulants; Disease Models, Animal; Drug Interactions; Female; Isoxazoles; Motor Activity; Paliperidone Palmitate; Poly I-C; Pregnancy; Prenatal Exposure Delayed Effects; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Time Factors	2011
Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: Relationship with liver delta6-desaturase expression. Schizophrenia research, 2011, Volume: 129, Issue:1 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drinking Water; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Haloperidol; Isoxazoles; Linoleoyl-CoA Desaturase; Liver; Male; Olanzapine; Paliperidone Palmitate; Pyrimidines; Quetiapine Fumarate; Rats; Rats, Long-Evans; Risperidone; RNA, Messenger	2011
Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents. Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:2 Topics: Adolescent; Aging; Antipsychotic Agents; Body Mass Index; Child; Child Development Disorders, Pervasive; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Mental Disorders; Paliperidone Palmitate; Polypharmacy; Psychotic Disorders; Pyrimidines; Risperidone; Sex Factors; Sexual Development	2011
Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Crime; Delayed-Action Preparations; Dibenzothiazepines; Female; Florida; Humans; Isoxazoles; Male; Medicaid; Middle Aged; Olanzapine; Outpatients; Paliperidone Palmitate; Piperazines; Propensity Score; Pyrimidines; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Schizophrenia; Treatment Outcome; United States; Young Adult	2011
MultiSimplex optimization of chromatographic separation and dansyl derivatization conditions in the ultra performance liquid chromatography-tandem mass spectrometry analysis of risperidone, 9-hydroxyrisperidone, monoamine and amino acid neurotransmitters Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Jul-01, Volume: 879, Issue:21 Topics: Biogenic Monoamines; Case-Control Studies; Chromatography, High Pressure Liquid; Dansyl Compounds; Humans; Isoxazoles; Multivariate Analysis; Neurotransmitter Agents; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Schizophrenia; Sensitivity and Specificity; Tandem Mass Spectrometry	2011
Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801. Neuroscience letters, 2011, Aug-18, Volume: 500, Issue:3 Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Extracellular Space; Female; Glutamic Acid; Isoxazoles; Male; Maternal Exposure; Paliperidone Palmitate; Poly I-C; Prefrontal Cortex; Pregnancy; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Risperidone; Schizophrenia	2011
Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:5 Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Monitoring; Female; Genotype; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult	2011
Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells. Progress in neuro-psychopharmacology & biological psychiatry, 2012, Jan-10, Volume: 36, Issue:1 Topics: Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Humans; Isoxazoles; Neuroblastoma; Neuroprotective Agents; Paliperidone Palmitate; Pyrimidines; Risperidone	2012
Enantioselective fungal biotransformation of risperidone in liquid culture medium by capillary electrophoresis and hollow fiber liquid-phase microextraction. Electrophoresis, 2011, Volume: 32, Issue:19 Topics: Analysis of Variance; Biotransformation; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Isoxazoles; Linear Models; Liquid Phase Microextraction; Mucor; Paliperidone Palmitate; Pilot Projects; Pyrimidines; Reproducibility of Results; Risperidone; Sensitivity and Specificity; Stereoisomerism	2011
Manic symptoms during a switch from risperidone to paliperidone: a case report. The Journal of neuropsychiatry and clinical neurosciences, 2011,Summer, Volume: 23, Issue:3 Topics: Antipsychotic Agents; Bipolar Disorder; Female; Follow-Up Studies; Humans; Isoxazoles; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia	2011
Anaphylactoid reaction to paliperidone palmitate extended-release injectable suspension in a patient tolerant of oral risperidone. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2012, Jan-01, Volume: 69, Issue:1 Topics: Administration, Oral; Adult; Anaphylaxis; Antipsychotic Agents; Delayed-Action Preparations; Humans; Injections, Intramuscular; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia; Suspensions	2012
[Case of schizophrenia in which depressive and negative symptoms relapsed on switching from oral risperidone to risperidone long-acting injection]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2011, Volume: 113, Issue:10 Topics: Administration, Ophthalmic; Antipsychotic Agents; Delayed-Action Preparations; Drug Substitution; Humans; Injections; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Receptors, Adrenergic, alpha-2; Recurrence; Risperidone; Schizophrenia; Schizophrenic Psychology	2011
Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:1 Topics: Animals; Antipsychotic Agents; Brain; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Isoxazoles; Macaca mulatta; Male; Paliperidone Palmitate; Positron-Emission Tomography; Protein Binding; Pyrimidines; Receptors, Dopamine D2; Risperidone	2012
Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone. The Journal of neuropsychiatry and clinical neurosciences, 2011,Fall, Volume: 23, Issue:4 Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Neuroleptic Malignant Syndrome; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone	2011
A change from risperidone long acting injection to paliperidone palmitate in an elderly patient--a cautionary tale. The Australian and New Zealand journal of psychiatry, 2012, Volume: 46, Issue:2 Topics: Aged; Antipsychotic Agents; Female; Humans; Isoxazoles; Paliperidone Palmitate; Palmitates; Recurrence; Risperidone; Schizophrenia; Treatment Failure	2012
Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats. Pharmaceutical research, 2012, Volume: 29, Issue:7 Topics: Animals; Antipsychotic Agents; Brain; Isoxazoles; Male; Models, Biological; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone	2012
Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database. PLoS medicine, 2012, Volume: 9, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Databases, Factual; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Publication Bias; Pyrimidines; Quetiapine Fumarate; Quinolones; Risperidone; United States; United States Food and Drug Administration	2012
Cost effectiveness of paliperidone palmitate versus risperidone long-acting injectable and olanzapine pamoate for the treatment of patients with schizophrenia in Sweden. Journal of medical economics, 2012, Volume: 15, Issue:5 Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Drug Substitution; Female; Health Resources; Humans; Injections; Isoxazoles; Male; Markov Chains; Models, Economic; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Recurrence; Risperidone; Schizophrenia; Sweden	2012
Risperidone and total 9-hydroxyrisperidone in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2002-2010. Therapeutic drug monitoring, 2012, Volume: 34, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Databases, Factual; Drug Monitoring; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Treatment Outcome; Young Adult	2012
Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein. Progress in neuro-psychopharmacology & biological psychiatry, 2012, Oct-01, Volume: 39, Issue:1 Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Brain; Cell Line, Transformed; Humans; Isoxazoles; LLC-PK1 Cells; Mice; Mice, Inbred Strains; Mice, Knockout; Paliperidone Palmitate; Piperazines; Piperidines; Pyrimidines; Risperidone; Swine	2012
Effect of the cytochrome P450 2D610 allele on risperidone metabolism in Japanese psychiatric patients. Human psychopharmacology, 2012, Volume: 27, Issue:1* Topics: Adult; Alleles; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Humans; Isoxazoles; Japan; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Young Adult	2012
Solid phase microextraction and LC-MS/MS for the determination of paliperidone after stereoselective fungal biotransformation of risperidone. Analytica chimica acta, 2012, Sep-12, Volume: 742 Topics: Biotransformation; Chromatography, Liquid; Culture Media; Cunninghamella; Isoxazoles; Molecular Structure; Paliperidone Palmitate; Pyrimidines; Risperidone; Solid Phase Microextraction; Solvents; Stereoisomerism; Tandem Mass Spectrometry	2012
An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:11 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Brain Chemistry; Dogs; Isoxazoles; Male; Paliperidone Palmitate; Primates; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Thiophenes	2012
Population pharmacokinetic modeling of risperidone and 9-hydroxyrisperidone to estimate CYP2D6 subpopulations in children and adolescents. Therapeutic drug monitoring, 2012, Volume: 34, Issue:5 Topics: Adolescent; Antipsychotic Agents; Child; Child, Preschool; Cohort Studies; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Isoxazoles; Male; Mental Disorders; Paliperidone Palmitate; Phenotype; Prospective Studies; Pyrimidines; Risperidone	2012
A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:8 Topics: Adult; Aged; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gas Chromatography-Mass Spectrometry; Humans; Injections, Intramuscular; Isoxazoles; Long-Term Care; Male; Middle Aged; Paliperidone Palmitate; Positron-Emission Tomography; Psychiatric Status Rating Scales; Pyrimidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult	2012
Risperidone/paliperidone induced neutropenia and lymphopenia. The Australian and New Zealand journal of psychiatry, 2013, Volume: 47, Issue:3 Topics: Antipsychotic Agents; Humans; Isoxazoles; Lymphopenia; Male; Middle Aged; Neutropenia; Paliperidone Palmitate; Pyrimidines; Risperidone	2013
Bacterial degradation of risperidone and paliperidone in decomposing blood. Journal of forensic sciences, 2013, Volume: 58, Issue:1 Topics: Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Stability; Forensic Toxicology; Gram-Positive Bacteria; Isoxazoles; Paliperidone Palmitate; Postmortem Changes; Pyrimidines; Risperidone; Specimen Handling; Spectrometry, Mass, Electrospray Ionization; Swine; Temperature	2013
Paliperidone as an alternative for risperidone in a case of schizophrenia with retrograde ejaculation. The Journal of neuropsychiatry and clinical neurosciences, 2012,Summer, Volume: 24, Issue:3 Topics: Adult; Antipsychotic Agents; Ejaculation; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Sexual Dysfunction, Physiological	2012
Effects of single or repeated silymarin administration on pharmacokinetics of risperidone and its major metabolite, 9-hydroxyrisperidone in rats. Xenobiotica; the fate of foreign compounds in biological systems, 2013, Volume: 43, Issue:3 Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Injections, Intravenous; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Silymarin	2013
Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate. International clinical psychopharmacology, 2013, Volume: 28, Issue:1 Topics: Adult; Age Factors; Antipsychotic Agents; Biomarkers; Drug Substitution; Female; Humans; Hyperprolactinemia; Injections; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Prolactin; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Recovery of Function; Risperidone; Sexual Behavior; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult	2013
Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:6 Topics: Adolescent; Adult; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Child; Child Development Disorders, Pervasive; Cross-Sectional Studies; Dose-Response Relationship, Drug; Gynecomastia; Humans; Hyperprolactinemia; Isoxazoles; Logistic Models; Male; Paliperidone Palmitate; Prolactin; Pyrimidines; Risperidone; Sexual Dysfunction, Physiological; Statistics, Nonparametric; Surveys and Questionnaires; Time Factors; Young Adult	2012
Treating residual insomnia in schizophrenia: examining the options. Acta psychiatrica Scandinavica, 2013, Volume: 127, Issue:1 Topics: Antipsychotic Agents; Central Nervous System Depressants; Humans; Isoxazoles; Melatonin; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Sleep Initiation and Maintenance Disorders	2013
LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood. Forensic science international, 2013, Jun-10, Volume: 229, Issue:1-3 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry	2013
Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia. Journal of psychosocial nursing and mental health services, 2013, Volume: 51, Issue:3 Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia	2013
Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum. Forensic science international, 2013, Jun-10, Volume: 229, Issue:1-3 Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cattle; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Drug Stability; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry	2013
Impact of the ABCB1 gene polymorphism on plasma 9-hydroxyrisperidone and active moiety levels in Japanese patients with schizophrenia. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:3 Topics: Adult; Age Factors; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Isoxazoles; Japan; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Regression Analysis; Risperidone; Schizophrenia; Young Adult	2013
Economic and clinical comparison of atypical depot antipsychotic drugs for treatment of chronic schizophrenia in the Czech Republic. Journal of medical economics, 2013, Volume: 16, Issue:9 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Czech Republic; Decision Support Techniques; Delayed-Action Preparations; Drug Costs; Economics, Pharmaceutical; Female; Humans; Isoxazoles; Male; Multivariate Analysis; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Young Adult	2013
Signalling profile differences: paliperidone versus risperidone. British journal of pharmacology, 2013, Volume: 170, Issue:3 Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Arrestins; beta-Arrestins; CHO Cells; Cricetinae; Cricetulus; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Inverse Agonism; Extracellular Signal-Regulated MAP Kinases; Histamine Agonists; Humans; Isoxazoles; Molecular Structure; Paliperidone Palmitate; Pyrimidines; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D2; Receptors, Histamine H1; Risperidone; Serotonin Receptor Agonists; Signal Transduction; Structure-Activity Relationship; Transfection	2013
Cost-effectiveness analysis of atypical long-acting antipsychotics for treating chronic schizophrenia in Finland. Journal of medical economics, 2013, Volume: 16, Issue:9 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Decision Support Techniques; Delayed-Action Preparations; Drug Costs; Economics, Pharmaceutical; Female; Finland; Humans; Isoxazoles; Male; Multivariate Analysis; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Young Adult	2013
The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys. Pharmacogenetics and genomics, 2013, Volume: 23, Issue:9 Topics: Adolescent; Alleles; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Child; Child Development Disorders, Pervasive; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Genetic Variation; Humans; Hyperprolactinemia; Isoxazoles; Male; Paliperidone Palmitate; Polymorphism, Genetic; Prolactin; Pyrimidines; Receptors, Dopamine D2; Risperidone; Young Adult	2013
Microsphere delivery of Risperidone as an alternative to combination therapy. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2013, Volume: 85, Issue:3 Pt A Topics: Animals; Antipsychotic Agents; Area Under Curve; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Delivery Systems; Isoxazoles; Lactic Acid; Male; Microspheres; Paliperidone Palmitate; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Time Factors	2013
Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics. CNS spectrums, 2014, Volume: 19, Issue:4 Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Female; Humans; Hypochondriasis; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Paliperidone Palmitate; Prevalence; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride	2014
Johnson & Johnson to pay $2.2bn to settle charges of false marketing on three drugs. BMJ (Clinical research ed.), 2013, Nov-06, Volume: 347 Topics: Consumer Product Safety; Drug Industry; Fraud; Humans; Isoxazoles; Marketing; Natriuretic Peptide, Brain; Paliperidone Palmitate; Pyrimidines; Risperidone; United States; United States Food and Drug Administration	2013
Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden. Nordic journal of psychiatry, 2014, Volume: 68, Issue:6 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost of Illness; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Female; Haloperidol; Health Care Costs; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Models, Econometric; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Sweden	2014
Atypical antipsychotics such as risperidone, but not paliperidone, worsen vascular endothelial function via upregulation of adhesion molecules VCAM-1, ICAM-1, and E-selectin in diabetic rats. Canadian journal of physiology and pharmacology, 2013, Volume: 91, Issue:12 Topics: Animals; Antipsychotic Agents; Aorta; Blood Pressure; Cell Adhesion Molecules; Chemokine CCL2; Cytokines; Diabetes Mellitus, Experimental; Diet, High-Fat; E-Selectin; Endothelium, Vascular; Glucose; Insulin Resistance; Isoxazoles; Lipids; Male; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Wistar; Risperidone; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Cell Adhesion Molecule-1	2013
Lower risk for body weight gain and better control of appetite after switching risperidone to paliperidone in a schizoaffective patient. The Journal of neuropsychiatry and clinical neurosciences, 2014, Apr-01, Volume: 26, Issue:2 Topics: Adult; Antipsychotic Agents; Appetite; Body Weight; Female; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone	2014
Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approach. Pharmaceutical research, 2014, Volume: 31, Issue:10 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Catalepsy; Computer Simulation; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Isoxazoles; Markov Chains; Models, Biological; Olanzapine; Paliperidone Palmitate; Pyrimidines; Rats; Receptors, Dopamine D2; Risperidone; Severity of Illness Index	2014
Relationship between the plasma concentration of paliperidone and the clinical and drug-induced extrapyramidal symptoms in elderly patients with schizophrenia. Human psychopharmacology, 2014, Volume: 29, Issue:3 Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Blood Chemical Analysis; Chromatography, Liquid; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prospective Studies; Pyrimidines; Risperidone; Schizophrenia; Severity of Illness Index; Tandem Mass Spectrometry; Treatment Outcome	2014
Generalized estimating equation model and long-term exposure effect of antipsychotics on SH-SY5Y cells against oxidative stressors. European journal of pharmacology, 2014, Oct-05, Volume: 740 Topics: 1-Methyl-4-phenylpyridinium; Amyloid beta-Peptides; Antipsychotic Agents; Benzodiazepines; Cell Line, Tumor; Cell Survival; Glutathione; Haloperidol; Humans; Hydrogen Peroxide; Models, Biological; Neuroprotective Agents; Olanzapine; Oxidative Stress; Paliperidone Palmitate; Peptide Fragments; Protein Carbonylation; Risperidone	2014
Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases. International journal of clinical practice, 2014, Volume: 68, Issue:12 Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Movement Disorders; Paliperidone Palmitate; Recurrence; Risperidone; Schizophrenia; Treatment Outcome	2014
Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database. International clinical psychopharmacology, 2015, Volume: 30, Issue:3 Topics: Administration, Oral; Adult; Antipsychotic Agents; Cohort Studies; Databases, Factual; Delayed-Action Preparations; Drug Administration Schedule; Drug Substitution; Female; Humans; Insurance Claim Review; Male; Medicaid; Middle Aged; Paliperidone Palmitate; Prospective Studies; Retrospective Studies; Risperidone; Schizophrenia; United States	2015
QTc modification after risperidone administration--insight into the mechanism of action with use of the modeling and simulation at the population level approach. Toxicology mechanisms and methods, 2015, Volume: 25, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Computer Simulation; Cytochrome P-450 CYP2D6; Electrocardiography; Female; Heart Rate; Humans; Ion Channels; Male; Myocardium; Myocytes, Cardiac; Paliperidone Palmitate; Quantitative Structure-Activity Relationship; Risperidone; Water-Electrolyte Balance; Young Adult	2015
Necrotising pyomyositis complicating intramuscular antipsychotic administration. BMJ case reports, 2015, Jun-08, Volume: 2015 Topics: Adult; Anti-Bacterial Agents; Antipsychotic Agents; Daptomycin; Female; Gram-Positive Cocci; Humans; Injections, Intramuscular; Muscle, Skeletal; Necrosis; Paliperidone Palmitate; Pyomyositis; Risperidone; Schizophrenia	2015
Concurrent determination of olanzapine, risperidone and 9-hydroxyrisperidone in human plasma by ultra performance liquid chromatography with diode array detection method: application to pharmacokinetic study. Biomedical chromatography : BMC, 2016, Volume: 30, Issue:2 Topics: Administration, Oral; Adult; Benzodiazepines; Chromatography, High Pressure Liquid; Drug Stability; Humans; Limit of Detection; Linear Models; Male; Olanzapine; Paliperidone Palmitate; Reproducibility of Results; Risperidone; Young Adult	2016
Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort. Clinical pharmacokinetics, 2015, Volume: 54, Issue:12 Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Cytochrome P-450 CYP2D6; Female; Humans; Longitudinal Studies; Male; Mental Disorders; Models, Biological; Paliperidone Palmitate; Polymorphism, Genetic; Prolactin; Retrospective Studies; Risperidone	2015
Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial. Schizophrenia bulletin, 2016, Volume: 42, Issue:1 Topics: Aged; Antipsychotic Agents; Benzodiazepines; Brain; Carbon Radioisotopes; Chromatography, Liquid; Female; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Positron-Emission Tomography; Prospective Studies; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia; Tandem Mass Spectrometry	2016
Pharmacoeconomics of long-acting atypical antipsychotics for acutely relapsed chronic schizophrenia in Finland. Journal of medical economics, 2016, Volume: 19, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Economics, Pharmaceutical; Female; Finland; Humans; Male; Olanzapine; Paliperidone Palmitate; Risperidone; Schizophrenia	2016
Risperidone and Venlafaxine Metabolic Ratios Strongly Predict a CYP2D6 Poor Metabolizing Genotype. Therapeutic drug monitoring, 2016, Volume: 38, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Child; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Paliperidone Palmitate; Predictive Value of Tests; Retrospective Studies; Risperidone; Sensitivity and Specificity; Venlafaxine Hydrochloride; Young Adult	2016
Regulation of P-glycoprotein expression in brain capillaries in Huntington's disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2016, Volume: 36, Issue:8 Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Blood-Brain Barrier; Capillaries; Gene Expression Regulation; HEK293 Cells; Humans; Huntingtin Protein; Huntington Disease; Mice, Transgenic; NF-kappa B; Paliperidone Palmitate; Reverse Transcriptase Polymerase Chain Reaction; Risperidone	2016
Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK. The journal of mental health policy and economics, 2015, Volume: 18, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Clozapine; Computer Simulation; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Administration Schedule; Humans; Injections, Intramuscular; Markov Chains; Models, Economic; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; State Medicine; United Kingdom	2015
Impact of CYP2D6 Polymorphism on Steady-State Plasma Levels of Risperidone and 9-Hydroxyrisperidone in Thai Children and Adolescents with Autism Spectrum Disorder. Journal of child and adolescent psychopharmacology, 2017, Volume: 27, Issue:2 Topics: Alleles; Antipsychotic Agents; Autism Spectrum Disorder; Child; Chromatography, Liquid; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Male; Paliperidone Palmitate; Polymorphism, Genetic; Real-Time Polymerase Chain Reaction; Risperidone; Tandem Mass Spectrometry; Thailand	2017
In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions: link to spatial receptor occupancy. Molecular psychiatry, 2016, Volume: 21, Issue:11 Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; Benzodiazepines; Blood-Brain Barrier; Brain; Cerebrospinal Fluid; Clozapine; Haloperidol; Male; Neuropharmacology; Olanzapine; Paliperidone Palmitate; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Risperidone	2016
Risperidone-induced hepatotoxicity in a patient addicted to synthetic cannabinoid. European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:3 Topics: Adult; Antipsychotic Agents; Cannabinoids; Chemical and Drug Induced Liver Injury; Drug Substitution; Humans; Male; Paliperidone Palmitate; Risk Factors; Risperidone; Substance Withdrawal Syndrome; Substance-Related Disorders	2016
9-Hydroxyrisperidone-Induced Hyperprolactinaemia in Thai Children and Adolescents with Autism Spectrum Disorder. Basic & clinical pharmacology & toxicology, 2016, Volume: 119, Issue:3 Topics: Adolescent; Autism Spectrum Disorder; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Hyperprolactinemia; Linear Models; Male; Multivariate Analysis; Paliperidone Palmitate; Prolactin; Risperidone; Thailand; Young Adult	2016
Add-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidone. Psychiatry research, 2016, Mar-30, Volume: 237 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Estradiol; Female; Humans; Hyperprolactinemia; Middle Aged; Paliperidone Palmitate; Prolactin; Risperidone; Schizophrenia; Treatment Outcome; Young Adult	2016
Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain. Clinical drug investigation, 2016, Volume: 36, Issue:6 Topics: Antipsychotic Agents; Cost Control; Cost Savings; Delayed-Action Preparations; Drug Costs; Health Care Costs; Hospitalization; Humans; Length of Stay; Models, Economic; Paliperidone Palmitate; Risperidone; Schizophrenia; Spain	2016
Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling of risperidone and its active metabolite in Chinese schizophrenia patients. International journal of clinical pharmacology and therapeutics, 2016, Volume: 54, Issue:5 Topics: Adult; Antipsychotic Agents; Area Under Curve; Asian People; Biotransformation; China; Female; Humans; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Paliperidone Palmitate; Phenotype; Risperidone; Schizophrenia; Schizophrenic Psychology	2016
Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study. Psychiatry research, 2016, 05-30, Volume: 239 Topics: Adult; Antipsychotic Agents; Female; Humans; Hyperprolactinemia; Male; Mental Disorders; Middle Aged; Paliperidone Palmitate; Prolactin; Risperidone	2016
Economic analysis of paliperidone long-acting injectable for chronic schizophrenia in Portugal. Journal of medical economics, 2016, Volume: 19, Issue:9 Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Delayed-Action Preparations; Haloperidol; Hospitalization; Humans; Olanzapine; Paliperidone Palmitate; Portugal; Quality-Adjusted Life Years; Recurrence; Risperidone; Schizophrenia	2016
Impact of Ageing on Serum Concentrations of Risperidone and Its Active Metabolite in Patients with Known CYP2D6 Genotype. Basic & clinical pharmacology & toxicology, 2016, Volume: 119, Issue:5 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Alleles; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Drug Monitoring; Female; Genotype; Humans; Male; Mental Disorders; Middle Aged; Norway; Paliperidone Palmitate; Retrospective Studies; Risperidone; Sex Factors; Young Adult	2016
Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions. Journal of psychopharmacology (Oxford, England), 2016, Volume: 30, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Databases, Factual; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Hypertension; Male; Mental Disorders; Metoprolol; Middle Aged; Paliperidone Palmitate; Retrospective Studies; Risperidone; Young Adult	2016
In vivo analysis of torsadogenic potential of an antipsychotic drug paliperidone using the acute atrioventricular block rabbit as a proarrhythmia model. Journal of pharmacological sciences, 2016, Volume: 132, Issue:1 Topics: Action Potentials; Animals; Antipsychotic Agents; Atrioventricular Block; Dose-Response Relationship, Drug; Male; Paliperidone Palmitate; Rabbits; Risperidone; Torsades de Pointes	2016
Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders. Journal of clinical laboratory analysis, 2016, Volume: 30, Issue:6 Topics: Antipsychotic Agents; Autism Spectrum Disorder; Chromatography, Liquid; Drug Monitoring; Female; Humans; Male; Paliperidone Palmitate; Risperidone; Statistics as Topic; Statistics, Nonparametric; Tandem Mass Spectrometry	2016
Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole. Clinical pharmacology in drug development, 2016, Volume: 5, Issue:6 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Specimen Collection; Capillaries; Female; Fingers; Half-Life; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Risperidone; Schizophrenia; Veins; Young Adult	2016
Pharmacokinetic patterns of risperidone-associated adverse drug reactions. European journal of clinical pharmacology, 2016, Volume: 72, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Paliperidone Palmitate; Risperidone; Young Adult	2016
Association of ABCB1 Gene Polymorphisms with Efficacy and Adverse Reaction to Risperidone or Paliperidone in Han Chinese Schizophrenic Patients. Neuroscience bulletin, 2016, Volume: 32, Issue:6 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Asian People; ATP Binding Cassette Transporter, Subfamily B; Female; Humans; Male; Mental Status Schedule; Middle Aged; Paliperidone Palmitate; Pharmacogenetics; Polymorphism, Single Nucleotide; Risperidone; Schizophrenia; Statistics, Nonparametric; Young Adult	2016
Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate. Current medical research and opinion, 2016, Volume: 32, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Female; Health Care Costs; Health Resources; Humans; Injections; Longitudinal Studies; Male; Middle Aged; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia	2016
Marked Improvement of Meige Syndrome in a Japanese Male Patient with Schizophrenia After Switching from Risperidone to Paliperidone: A Case Report. Journal of UOEH, 2016, Volume: 38, Issue:3 Topics: Adult; Antipsychotic Agents; Humans; Male; Meige Syndrome; Paliperidone Palmitate; Risperidone; Schizophrenia; Treatment Outcome	2016
Plasma levels and estimated dopamine D Psychopharmacology, 2016, Volume: 233, Issue:23-24 Topics: Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Cross-Sectional Studies; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Maintenance Chemotherapy; Male; Middle Aged; Paliperidone Palmitate; Receptors, Dopamine D2; Risperidone; Schizophrenia	2016
In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [ Molecular psychiatry, 2016, Volume: 21, Issue:12 Topics: Adult; Antipsychotic Agents; Brain; Female; Gyrus Cinguli; Humans; Isoquinolines; Male; Microglia; Paliperidone Palmitate; Positron-Emission Tomography; Receptors, GABA; Risperidone; Schizophrenia	2016
Effects of Discontinuation of Paliperidone Long-Acting Injectable After Switching from Risperidone Long-Acting Injectable Switching. Psychopharmacology bulletin, 2016, Aug-15, Volume: 46, Issue:2 Topics: Antipsychotic Agents; Delayed-Action Preparations; Humans; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia	2016
Paliperidone palmitate: factors predicting continuation with treatment at 2 years. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Antipsychotic Agents; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Recurrence; Risk Assessment; Risperidone; Schizophrenia; Socioeconomic Factors; Young Adult	2016
Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment. Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Lamotrigine; Male; Middle Aged; Paliperidone Palmitate; Risperidone; Triazines; Valproic Acid; Young Adult	2016
Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study. Psychopharmacology, 2017, Volume: 234, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Drug Substitution; Female; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Patient Satisfaction; Prospective Studies; Risperidone; Schizophrenia; Surveys and Questionnaires; Treatment Outcome	2017
Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat. Drug metabolism and disposition: the biological fate of chemicals, 2017, Volume: 45, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Cerebrospinal Fluid; Extracellular Fluid; Male; Microdialysis; Models, Biological; Paliperidone Palmitate; Prolactin; Rats, Wistar; Risperidone; Tissue Distribution	2017
Effect of smoking on risperidone pharmacokinetics - A multifactorial approach to better predict the influence on drug metabolism. Schizophrenia research, 2017, Volume: 185 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paliperidone Palmitate; Retrospective Studies; Risperidone; Severity of Illness Index; Smoking; Young Adult	2017
Cytochrome P450-mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacy. British journal of clinical pharmacology, 2017, Volume: 83, Issue:8 Topics: Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Female; Humans; Male; Mental Disorders; Middle Aged; Paliperidone Palmitate; Perazine; Polypharmacy; Retrospective Studies; Risperidone	2017
Inhibition of cloned hERG potassium channels by risperidone and paliperidone. Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:6 Topics: Antipsychotic Agents; Cell Membrane; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Inhibitory Concentration 50; Paliperidone Palmitate; Patch-Clamp Techniques; Risperidone	2017
Validation of a dried blood spot method for therapeutic drug monitoring of citalopram, mirtazapine and risperidone and its active metabolite 9-hydroxyrisperidone using HPLC-MS. Journal of pharmaceutical and biomedical analysis, 2017, Jun-05, Volume: 140 Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Citalopram; Dried Blood Spot Testing; Drug Monitoring; Humans; Mianserin; Mirtazapine; Paliperidone Palmitate; Reproducibility of Results; Risperidone; Tandem Mass Spectrometry	2017
Assessments of plasma concentrations, pathology symptoms, and cognition following paliperidone treatment in schizophrenic patients previously treated with risperidone. Asian journal of psychiatry, 2017, Volume: 26 Topics: Antipsychotic Agents; Cognition; Female; Humans; Male; Middle Aged; Paliperidone Palmitate; Prospective Studies; Risperidone; Schizophrenia	2017
Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study. PloS one, 2017, Volume: 12, Issue:6 Topics: Adult; Antipsychotic Agents; Belgium; Benzodiazepines; Delayed-Action Preparations; Drug Administration Schedule; Female; Haloperidol; Humans; Medication Adherence; Netherlands; Olanzapine; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome	2017
Determination of Plasma Concentration Reference Ranges for Risperidone and Paliperidone. CPT: pharmacometrics & systems pharmacology, 2017, Volume: 6, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Child; Child, Preschool; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Models, Biological; Paliperidone Palmitate; Reference Values; Risperidone; Young Adult	2017
Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands. Journal of medical economics, 2017, Volume: 20, Issue:11 Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Delayed-Action Preparations; Haloperidol; Humans; Netherlands; Olanzapine; Paliperidone Palmitate; Quality-Adjusted Life Years; Recurrence; Risperidone; Schizophrenia	2017
Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics. Clinical therapeutics, 2017, Volume: 39, Issue:10 Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cost Savings; Delayed-Action Preparations; Female; Health Care Costs; Hospitalization; Humans; Injections; Long-Term Care; Male; Medicaid; Medication Adherence; Middle Aged; Olanzapine; Paliperidone Palmitate; Practice Patterns, Physicians'; Risperidone; Schizophrenia; United States; Young Adult	2017
Modeling of prolactin response following dopamine D Pharmacology research & perspectives, 2017, Volume: 5, Issue:6 Topics: Animals; Dopamine D2 Receptor Antagonists; Humans; Male; Models, Biological; Paliperidone Palmitate; Prolactin; Rats; Rats, Wistar; Remoxipride; Risperidone; Software	2017
Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France. Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:1 Topics: Adult; Antipsychotic Agents; Cohort Studies; Delayed-Action Preparations; Female; Follow-Up Studies; France; Hospitalization; Humans; Injections; Length of Stay; Male; Middle Aged; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome	2018
The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia. BMC psychiatry, 2018, 01-29, Volume: 18, Issue:1 Topics: Administration, Oral; Adult; Ambulatory Care; Antipsychotic Agents; Bipolar Disorder; Community Mental Health Services; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Paliperidone Palmitate; Practice Patterns, Physicians'; Prospective Studies; Risperidone; Schizophrenia; United States	2018
Long-Acting Injectable Atypical Antipsychotic Use in Adolescents: An Observational Study. Journal of child and adolescent psychopharmacology, 2018, Volume: 28, Issue:4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Child; Delayed-Action Preparations; Female; Hospitalization; Humans; Inpatients; Male; Off-Label Use; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Retrospective Studies; Risperidone; Treatment Outcome	2018
A water-compatible magnetic molecularly imprinted polymer for the selective extraction of risperidone and 9-hydroxyrisperidone from human urine. Talanta, 2018, May-01, Volume: 181 Topics: Chromatography, High Pressure Liquid; Humans; Magnetics; Microscopy, Electron; Molecular Imprinting; Paliperidone Palmitate; Polymers; Reproducibility of Results; Risperidone; Solid Phase Extraction; Water	2018
Quantitative determination of risperidone, paliperidone and olanzapine in human serum by liquid chromatography-tandem mass spectrometry coupled with on-line solid-phase extraction. Biomedical chromatography : BMC, 2018, Volume: 32, Issue:7 Topics: Benzodiazepines; Chromatography, High Pressure Liquid; Drug Stability; Humans; Limit of Detection; Linear Models; Olanzapine; Paliperidone Palmitate; Reproducibility of Results; Risperidone; Solid Phase Extraction; Tandem Mass Spectrometry	2018
Changes in length of hospital stay and number of hospitalization before and after the administration of three second-generation antipsychotics long-acting injections in patients with schizophrenia: Mirror-image study. Asian journal of psychiatry, 2018, Volume: 34 Topics: Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Female; Hospitalization; Humans; Length of Stay; Male; Paliperidone Palmitate; Risperidone; Schizophrenia; Treatment Outcome	2018
Risperidone-associated sinus tachycardia potentiated by paliperidone palmitate in a patient with no prior cardiovascular disease: role of risperidone-related autonomic instability. BMJ case reports, 2018, Apr-21, Volume: 2018 Topics: Antipsychotic Agents; Autonomic Nervous System; Cardiovascular Diseases; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Humans; Male; Paliperidone Palmitate; Risperidone; Schizophrenia; Tachycardia, Sinus; Treatment Outcome; Young Adult	2018
Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulations. International journal of clinical practice, 2018, Volume: 72, Issue:6 Topics: Administration, Oral; Antipsychotic Agents; Delayed-Action Preparations; Humans; Paliperidone Palmitate; Practice Guidelines as Topic; Risperidone; Schizophrenia	2018
Mortality rate is associated with paliperidone palmitate, risperidone long-acting injection, and oral paliperidone administration. Asian journal of psychiatry, 2018, Volume: 35 Topics: Administration, Oral; Adult; Antipsychotic Agents; Cohort Studies; Delayed-Action Preparations; Female; Humans; Japan; Male; Middle Aged; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia	2018
Prolactin levels: sex differences in the effects of risperidone, 9-hydroxyrisperidone levels, CYP2D6 and ABCB1 variants. Pharmacogenomics, 2018, 07-01, Volume: 19, Issue:10 Topics: Adult; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2D6; Female; Genetic Association Studies; Genotype; Haplotypes; Humans; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Risperidone; Sex Characteristics	2018
Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder. Journal of comparative effectiveness research, 2018, Volume: 7, Issue:11 Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Databases, Factual; Delayed-Action Preparations; Female; Hospitalization; Humans; Injections; Male; Medicaid; Middle Aged; Paliperidone Palmitate; Risperidone; Schizophrenia; United States; Young Adult	2018
Comparisons of the effects of second-generation antipsychotics long-acting injections on treatment retention according to severity of patient condition. Asian journal of psychiatry, 2018, Volume: 37 Topics: Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Female; Humans; Injections; Japan; Male; Medication Adherence; Middle Aged; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Severity of Illness Index	2018
Treatment Continuation of 3 Second-Generation Antipsychotic Long-Acting Injections, and Oral Paliperidone in Patients With Schizophrenia for 2 Years. Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:6 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Cohort Studies; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Injections; Male; Middle Aged; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome	2018
Studies of Half-Lives of Long-Acting Antipsychotics are Needed. Pharmacopsychiatry, 2019, Volume: 52, Issue:1 Topics: Antipsychotic Agents; Delayed-Action Preparations; Half-Life; Humans; Injections, Intramuscular; Paliperidone Palmitate; Risperidone	2019
Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance). International clinical psychopharmacology, 2019, Volume: 34, Issue:2 Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Child; Databases, Factual; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Pharmacovigilance; Pituitary Neoplasms; Pregnancy; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sulpiride; Young Adult	2019
Analysis of smoking behavior on the pharmacokinetics of antidepressants and antipsychotics: evidence for the role of alternative pathways apart from CYP1A2. International clinical psychopharmacology, 2019, Volume: 34, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Antipsychotic Agents; Clozapine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Desvenlafaxine Succinate; Doxepin; Drug Monitoring; Female; Glucuronosyltransferase; Humans; Male; Middle Aged; Mirtazapine; Nortriptyline; Paliperidone Palmitate; Quetiapine Fumarate; Retrospective Studies; Risperidone; Smoking; Venlafaxine Hydrochloride	2019
Acute agranulocytosis when switching from risperidone to paliperidone. The Australian and New Zealand journal of psychiatry, 2019, Volume: 53, Issue:6 Topics: Adolescent; Agranulocytosis; Antipsychotic Agents; Comorbidity; Drug Substitution; Humans; Male; Neurofibromatosis 1; Paliperidone Palmitate; Psychotic Disorders; Risperidone	2019
Physiologically Based Modeling Approach to Predict Dopamine D2 Receptor Occupancy of Antipsychotics in Brain: Translation From Rat to Human. Journal of clinical pharmacology, 2019, Volume: 59, Issue:5 Topics: Animals; Antipsychotic Agents; Brain; Clozapine; Dopamine D2 Receptor Antagonists; Female; Humans; Kinetics; Male; Models, Biological; Paliperidone Palmitate; Rats; Receptors, Dopamine D2; Risperidone; Translational Research, Biomedical	2019
Retrospective Analysis of the Effectiveness and Tolerability of Long-Acting Paliperidone Palmitate Antipsychotic in Adolescent First-Episode Schizophrenia Patients. Journal of child and adolescent psychopharmacology, 2019, Volume: 29, Issue:3 Topics: Adolescent; Antipsychotic Agents; Brief Psychiatric Rating Scale; Female; Hospitalization; Humans; Hyperprolactinemia; Male; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Weight Gain	2019
Metabolism of risperidone by CYP2D6 and the presence of drug-induced dopamine supersensitivity psychosis in patients with schizophrenia. International clinical psychopharmacology, 2019, Volume: 34, Issue:3 Topics: Alleles; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Dopamine; Genotype; Humans; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Psychotic Disorders; Risperidone; Schizophrenia	2019
Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia. Journal of medical economics, 2019, Volume: 22, Issue:11 Topics: Administration, Oral; Adult; Age Factors; Antipsychotic Agents; Aripiprazole; Comorbidity; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Insurance Claim Review; Kaplan-Meier Estimate; Longitudinal Studies; Male; Medicaid; Medication Adherence; Middle Aged; Paliperidone Palmitate; Proportional Hazards Models; Racial Groups; Retrospective Studies; Risperidone; Schizophrenia; Sex Factors; United States	2019
[Therapeutic drug monitoring of risperidone and its active metabolite 9-hydroxyrisperidone in the treatment of schizophrenia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2019, Volume: 119, Issue:3 Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia	2019
Real-life persistence of long-acting injectable antipsychotics in schizophrenic patients: A retrospective observational study in France . International journal of clinical pharmacology and therapeutics, 2019, Volume: 57, Issue:9 Topics: Antipsychotic Agents; Delayed-Action Preparations; France; Haloperidol; Humans; Injections; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia	2019
Factors That Affect Continuation of Antipsychotic Long-Acting Injections. Biological & pharmaceutical bulletin, 2019, Volume: 42, Issue:7 Topics: Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Female; Humans; Male; Medication Adherence; Middle Aged; Paliperidone Palmitate; Risperidone; Schizophrenia	2019
Physiologically Based Pharmacokinetic Modelling to Describe the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone According to Cytochrome P450 2D6 Phenotypes. Clinical pharmacokinetics, 2020, Volume: 59, Issue:1 Topics: Administration, Oral; Adult; Antipsychotic Agents; Clinical Decision-Making; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Genotype; Humans; Male; Models, Theoretical; Paliperidone Palmitate; Phenotype; Polymorphism, Genetic; Risperidone	2020
Continuation of schizophrenia treatment with three long-acting injectable antipsychotics in South Korea: A nationwide population-based study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2019, Volume: 29, Issue:9 Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections; Male; Paliperidone Palmitate; Patient Acceptance of Health Care; Republic of Korea; Risperidone; Schizophrenia	2019
Influence of Kidney Function on Serum Risperidone Concentrations in Patients Treated With Risperidone. The Journal of clinical psychiatry, 2019, 11-26, Volume: 80, Issue:6 Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Germany; Humans; Kidney Function Tests; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Renal Elimination; Risperidone; Schizophrenia	2019
Royal Eschizophilia. Genealogical delusion or Mignon delusion as a pathoplastic realization. Actas espanolas de psiquiatria, 2019, Volume: 47, Issue:6 Topics: Age Factors; Antipsychotic Agents; Carbamazepine; Delusions; Disease Progression; Fellowships and Scholarships; Female; Genealogy and Heraldry; Hallucinations; Humans; Middle Aged; Paliperidone Palmitate; Piperazines; Risperidone; Thiazoles; Time Factors	2019
Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy. Clinical therapeutics, 2020, Volume: 42, Issue:1 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Female; Health Care Costs; Hospitalization; Humans; Lurasidone Hydrochloride; Male; Medicaid; Medicare; Middle Aged; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Thiophenes; United States	2020
Successful Long-Acting Paliperidone Treatment Following Reversible Risperidone-Induced Neutropenia. The primary care companion for CNS disorders, 2020, 04-02, Volume: 22, Issue:2 Topics: Adolescent; Antipsychotic Agents; Delayed-Action Preparations; Female; Humans; Neutropenia; Paliperidone Palmitate; Risperidone; Schizophrenia	2020
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach. Pharmaceutical research, 2020, May-31, Volume: 37, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Antipsychotic Agents; Computer Simulation; Cytochrome P-450 CYP2D6; Datasets as Topic; Female; Humans; Male; Metabolic Clearance Rate; Models, Biological; Paliperidone Palmitate; Psychotic Disorders; Risperidone; Time Factors; Young Adult	2020
Field-amplified sample injection in capillary zone electrophoresis for the pharmacokinetic research of trace risperidone and its major metabolite 9-hydroxyrisperidone in beagle dogs. Journal of separation science, 2020, Volume: 43, Issue:17 Topics: Animals; Dogs; Electrophoresis, Capillary; Female; Flow Injection Analysis; Male; Molecular Structure; Paliperidone Palmitate; Risperidone	2020
Long-acting injectable antipsychotics: choosing the right dose. Journal of psychiatry & neuroscience : JPN, 2020, 07-01, Volume: 45, Issue:4 Topics: Antipsychotic Agents; Delayed-Action Preparations; Disease Progression; Drug Substitution; Humans; Injections, Intramuscular; Male; Middle Aged; Paliperidone Palmitate; Risperidone; Schizophrenia	2020
Risperidone plasma concentrations are associated with side effects and effectiveness in children and adolescents with autism spectrum disorder. British journal of clinical pharmacology, 2021, Volume: 87, Issue:3 Topics: Adolescent; Antipsychotic Agents; Autism Spectrum Disorder; Child; Cytochrome P-450 CYP2D6; Humans; Male; Paliperidone Palmitate; Risperidone	2021
[Some current trends in the use of prolonged injectable antipsychotics in the conditions of modernization of the psychiatric service]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2020, Volume: 120, Issue:6. Vyp. 2 Topics: Antipsychotic Agents; Delayed-Action Preparations; Humans; Moscow; Paliperidone Palmitate; Risperidone; Social Change	2020
Identification and Quantification of Antipsychotics in Blood Samples by LC-MS-MS: Case Reports and Data from Three Years of Routine Analysis. Journal of analytical toxicology, 2020, Dec-12, Volume: 44, Issue:8 Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Humans; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Substance Abuse Detection; Suicide; Sulpiride; Tandem Mass Spectrometry; Thiazoles	2020
[Rhabdomyolysis induced by paliperidone palmitate]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2021, Volume: 35, Issue:2 Topics: Antipsychotic Agents; Humans; Male; Middle Aged; Paliperidone Palmitate; Rhabdomyolysis; Risperidone; Schizophrenia	2021
Dose-Corrected Serum Concentrations and Metabolite to Parent Compound Ratios of Venlafaxine and Risperidone from Childhood to Old Age. Pharmacopsychiatry, 2021, Volume: 54, Issue:3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Child; Cross-Sectional Studies; Female; Humans; Paliperidone Palmitate; Risperidone; Venlafaxine Hydrochloride	2021
A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models. PloS one, 2021, Volume: 16, Issue:1 Topics: Animals; Antipsychotic Agents; Female; Glucose Clamp Technique; Glucose Tolerance Test; Insulin Resistance; Metabolic Diseases; Models, Animal; Paliperidone Palmitate; Rats; Rats, Sprague-Dawley; Risperidone	2021
Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone. BMC psychiatry, 2021, 02-03, Volume: 21, Issue:1 Topics: Antipsychotic Agents; Cytochrome P-450 CYP2D6; Humans; Isoxazoles; Paliperidone Palmitate; Plasma; Pyrimidines; Risperidone	2021
Factors influencing the effect of aripiprazole on prolactin levels in patients treated with risperidone or paliperidone. Sex seems to matter. Schizophrenia research, 2021, Volume: 228 Topics: Antipsychotic Agents; Aripiprazole; Humans; Paliperidone Palmitate; Prolactin; Risperidone	2021
Fatal and life-threatening ADRs associated with paliperidone palmitate: an observational study in the French pharmacovigilance database. Clinical toxicology (Philadelphia, Pa.), 2021, Volume: 59, Issue:9 Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Drug-Related Side Effects and Adverse Reactions; Female; France; Humans; Male; Middle Aged; Paliperidone Palmitate; Pharmacovigilance; Retrospective Studies; Risperidone; Schizophrenia; Sex Factors; Young Adult	2021
Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone. Scientific reports, 2021, 02-18, Volume: 11, Issue:1 Topics: Alleles; Antipsychotic Agents; Child; Cytochrome P-450 CYP2D6; Female; Gene Frequency; Genotype; Humans; Male; Paliperidone Palmitate; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Risperidone; Thailand	2021
Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels. Neuropsychopharmacology reports, 2021, Volume: 41, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Female; Genetic Diseases, Inborn; Humans; Hyperprolactinemia; Lactation Disorders; Male; Paliperidone Palmitate; Prolactin; Risperidone; Schizophrenia; Testosterone	2021
Comparison of treatment retention between risperidone long-acting injection, paliperidone palmitate, and aripiprazole once-monthly in elderly patients with schizophrenia. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2022, Volume: 22, Issue:1 Topics: Aged; Antipsychotic Agents; Aripiprazole; Humans; Paliperidone Palmitate; Risperidone; Schizophrenia	2022
Risperidone is not only a prodrug: psychosis induced by medication switch from risperidone to paliperidone - a case report. European journal of hospital pharmacy : science and practice, 2023, Volume: 30, Issue:4 Topics: Antipsychotic Agents; Delayed-Action Preparations; Humans; Male; Paliperidone Palmitate; Prodrugs; Psychotic Disorders; Risperidone; Schizophrenia	2023
Population Pharmacokinetic Modeling and Simulation of TV-46000: A Long-Acting Injectable Formulation of Risperidone. Clinical pharmacology in drug development, 2022, Volume: 11, Issue:7 Topics: Antipsychotic Agents; Delayed-Action Preparations; Humans; Paliperidone Palmitate; Receptors, Dopamine D2; Risperidone	2022
Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone. Journal of neural transmission (Vienna, Austria : 1996), 2022, Volume: 129, Issue:5-6 Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Child; Drug Monitoring; Humans; Paliperidone Palmitate; Psychotic Disorders; Risperidone; Schizophrenia	2022
Precision psychiatry: The complexity of personalizing antipsychotic dosing. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2022, Volume: 58 Topics: Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Female; Humans; Male; Paliperidone Palmitate; Psychiatry; Risperidone	2022
Assessment of risk factors of treatment discontinuation among patients on paliperidone palmitate and risperidone microspheres in France, Germany and Belgium. BMC psychiatry, 2022, 06-07, Volume: 22, Issue:1 Topics: Adult; Antipsychotic Agents; Belgium; Delayed-Action Preparations; Female; Humans; Male; Microspheres; Middle Aged; Paliperidone Palmitate; Risk Factors; Risperidone	2022
Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019. Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:9 Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Drug-Related Side Effects and Adverse Reactions; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia	2022
Suicidality and psychotic episodes after starting aripiprazole: two case reports. International clinical psychopharmacology, 2022, 09-01, Volume: 37, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Humans; Male; Paliperidone Palmitate; Risperidone; Suicide	2022
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2022,Summer, Volume: 33, Issue:2 Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine	2022
Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan. The Journal of clinical psychiatry, 2022, 08-03, Volume: 83, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Japan; Paliperidone Palmitate; Risperidone; Schizophrenia; Tardive Dyskinesia	2022
Switching from risperidone to paliperidone palmitate in schizophrenia: Changes in social functioning and cognitive performance. Progress in neuro-psychopharmacology & biological psychiatry, 2023, 01-10, Volume: 120 Topics: Antipsychotic Agents; Cognition; Delayed-Action Preparations; Humans; Paliperidone Palmitate; Risperidone; Schizophrenia; Social Interaction	2023
Aripiprazole: examining the clinical implications of D2 affinity. International clinical psychopharmacology, 2023, 03-01, Volume: 38, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Humans; Paliperidone Palmitate; Risperidone; Schizophrenia	2023
Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate. Clinical and translational science, 2023, Volume: 16, Issue:4 Topics: Adult; Child; Cytochrome P-450 CYP2D6; Female; Humans; Infant, Newborn; Models, Biological; Paliperidone Palmitate; Pregnancy; Pregnant Women; Risperidone	2023
Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan. Schizophrenia research, 2023, Volume: 252 Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Japan; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia	2023
Can multisite clinical trial results change clinical practice? Use of long-acting injectable risperidone nationally in the Veterans Health Administration. Trials, 2023, Feb-06, Volume: 24, Issue:1 Topics: Antipsychotic Agents; Delayed-Action Preparations; Humans; Injections; Paliperidone Palmitate; Risperidone; Veterans Health	2023
A liquid chromatography-miniature mass spectrometry (LC-Mini MS) method for quantitative analysis of risperidone and 9-hydroxyrisperidone in plasma. The Analyst, 2023, Jul-26, Volume: 148, Issue:15 Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry	2023
Relationship between clinical efficacy and plasma concentration-dose ratio of risperidone in patients with schizophrenia. International clinical psychopharmacology, 2024, Jan-01, Volume: 39, Issue:1 Topics: Antipsychotic Agents; Female; Humans; Male; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome	2024